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This study addressed the factors that predict employee response to large-scale change in 
the United States pharmaceutical industry. When poorly executed, major organizational 
changes such as mergers and acquisitions are often disruptive and costly to organizations 
and demoralizing to employees. Although employee responses to change have been 
studied in several industries, employee responses during change execution in the 
pharmaceutical industry have not been subject to study. The purpose of this correlational 
study was to reduce the knowledge gap related to organizational change in the 
pharmaceutical industry by evaluating key predictors of employee response to large-scale 
change. The theoretical framework consisted of transformational leadership, stakeholder, 
and change management theories. The research questions focused on 4 key predictors 
(initial change reaction, change communication, involvement in change development, and 
perceived change success) and their effect on 2 primary dependent variables: reaction to 
change (RC) and support of change (SC). Ninety-eight participants completed the survey 
and multiple regression was used to measure associations between predictor variables and 
dependent variables. The 4 independent variables in the aggregate predicted RC and the 
championing subscale of SC. Individually, none of the independent variables predicted 
RC, SC, or any of the SC subscales. The study contributes to positive social change by 
providing leadership with information in guiding creation of a supportive work 
environment during organizational change and to inspire employees developing medical 
innovations to fulfill global health needs, while creating skilled jobs and generating 
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Chapter 1: Introduction 
 Change has become commonplace in organizations in the United States and 
around the world. According to Bordia, Restubog, Jimmieson, and Irmer (2011) and Jaros 
(2010), the reasons for this are numerous and include the demands of increasing 
globalization and deregulation, the results of mergers and acquisitions (M&As), changes 
associated with restructuring or downsizing, as well as the drive to gain competitive edge 
and strategic adaptability. These large-scale organizational changes have a significant 
potential to disrupt business as usual for organizations, and according to Bordia et al., can 
have profound implications for employees. Deeg (2009) also noted that these disruptions 
affect organizational performance. Consequently, the study of change initiatives and 
change management has become important to business and organizational researchers, 
and caused employee response to change to become an important area of research (Jaros, 
2010). 
 Successful change execution requires some understanding of the factors that 
predict employee response to change. Multiple researchers such as Goksoy, Ozsoy, and 
Vayvay (2012); Herscovitch and Meyer (2002); Lau and Woodman (1995); and Oreg and 
Sverdlik (2011), studied employee response to large-scale change in other industries, but 
gave little attention to employee response during large-scale change execution in the 
pharmaceutical industry. Large-scale change is common in the pharmaceutical industry, 
as it is subject to frequent M&As, a type of large-scale change phenomenon Hornke 
(2010) and Hornke and Mandewirth (2010) described as a business strategy that 




advantage. Shibayama, Tanikawa, and Kimura (2011) further noted that M&As are one 
of the main drivers of change in the pharmaceutical industry and are used as an essential 
strategic measure.  
 Employees respond to change, such as M&As, either by supporting or resisting it. 
An instrument for studying employee response to change is the Behavioral Support for 
Change Scale (BSCS; Herscovitch & Meyer, 2002).  Georgalis, Samaratunge, and 
Kimberley (2015) studied the effects of Australian employees’ feelings of justice and 
fairness on resistance to change, finding that feelings of justice had a mediating effect on 
change resistance. Lysova, Richardson, Khapova, and Jansen (2015) also studied 
employee support of change by examining the relationship with career identity, finding 
that employees actively engaged in career-seeking behaviors were more likely to display 
supportive change behaviors than those who were more passive. Oreg (2003) used the 
Resistance to Change Scale to assess whether a person is inclined to resist change. These 
approaches are appropriate for understanding employee response to change (i.e., support 
or resistance). However, these studies focused on organizations outside the 
pharmaceutical industry. 
 Research into employee reaction and engagement during large-scale change in the 
pharmaceutical industry is lacking, in spite of the high-risk nature of the industry and the 
consequences of poor change execution. For example, a drug costs $1.8 billion from 
discovery to commercialization (Golec, Hegde, & Vernon, 2010). During the course of 
this expensive, heavily regulated, and lengthy drug development process, companies 




effective change management, which makes it important to understand the key factors 
that predict employee support of change in the pharmaceutical industry. However, these 
factors have not been studied in-depth in the research literature on large-scale 
organizational change in the pharmaceutical industry. 
 This study was designed to understand and document employee reactions that 
indicate their level of reaction to change or support of change. Herscovitch and Meyer 
(2002) identified three operationalized measures of support of change: compliance 
(minimum supportive behavior), cooperation (more supportive), and championing (the 
highest level of support). These operationalized measures, along with active and passive 
resistance, encompass reaction to change and form the full spectrum of employee 
response to change examined in my study. I addressed the lack of knowledge and 
understanding about employee response to change by examining whether any of four 
factors (initial change reaction, change communication, involvement in change 
development, and perceived change success) predict employee response to large-scale 
change initiatives. This study was also designed to provide practical information on 
employee response to change to inform pharmaceutical managers and associated change 
leaders who are planning and implementing change. 
 In the remainder of this chapter, I will offer the background of the study, state the 
research problem and the purpose of the study, lay out the research questions, and outline 
the theoretical framework for the study, which is a synthesis of transformational 




this quantitative, correlational study; offer a definition of key terms and variables; and 
address assumptions, limitations, and delimitations of the study. 
Background 
Pharmaceutical research and development (R&D) is the cornerstone of one of the 
most expensive and high-risk global industries, and plays a crucial role in addressing the 
world’s present and future health needs. In the global pharmaceutical industry, only one 
in 10,000 discovered compounds make it to market (Cook, Hunter, & Vernon, 2009); 
because of this, bringing a pharmaceutical compound to market costs an average of $1.8 
billion (Golec et al., 2010). Regulatory agencies around the world, such as the United 
States Food and Drug Administration (FDA) and the European Medicines Agency 
(EMA), also heavily regulate the industry, and pharmaceutical companies must meet 
strict requirements before a drug is approved for marketing (Van Doren, 2011; Wechsler, 
2009). These challenges create pressure on the pharmaceutical industry to find ways to 
operate more efficiently. A common approach in the industry is to engage in M&As as a 
key strategic measure that affects multiple processes, employees, and departments 
(Hornke, 2009; Hornke & Mandewirth, 2010).  
M&As are examples of large-scale change initiatives; all organizations 
experiencing large-scale change initiatives must manage them well to avoid negative 
consequences. Deeg (2009) observed that change of this magnitude has the potential to 
disrupt a company’s performance, success, and growth if not handled effectively and 
efficiently. Barcan (2010) echoed this sentiment by elaborating further on the need for an 




The expensive and high-risk nature of the pharmaceutical industry suggests that the large-
scale organizational changes resulting from mergers and acquisitions have a similar 
potential to disrupt not only company productivity and revenue, but also employee 
commitment.  
Although research exists on employee response to change in other areas of 
business and industry, no research exists that specifically identified the factors that 
predict employee compliance, cooperation, and championing of change in the 
pharmaceutical industry. Goksoy et al. (2012) and Oreg and Sverdlik (2011), for 
example, examined the importance of understanding employee response during change 
implementation, but not in pharmaceutical industry settings. Therefore, in this study, I 
examined whether several factors predict employee support or reaction to large-scale 
change initiatives, such as M&As, in the pharmaceutical industry. The specific factors 
that I investigated were the following:  
 change communication,  
 initial change reaction,  
 involvement in change development, and  
 perceived change success. 
Employee support was measured in terms of compliance, cooperation, and championing. 
Knowledge of these factors is crucial for developing effective change 
management strategies that minimize the potential disruptive effects on employees and 
business operations. Effective change management is extremely important in the area of 




was designed to address the gap in scholarly research on change management in the 
pharmaceutical industry. The results of this study have practical implications for guiding 
the creation of a supportive work environment during organizational change—a 
transitional environment in which employees are motivated and engaged in their jobs to 
meet health and medical needs globally, while the companies create skilled jobs and 
generate profit. 
Problem Statement 
Multiple researchers have sought to understand employee engagement and 
response during large-scale change initiatives in nonpharmaceutical industries (Goksoy et 
al., 2012; Herscovitch & Meyer, 2002; Lau & Woodman, 1995; Oreg & Sverdlik, 2011). 
According to Budhwar, Varma, Katou, and Narayan (2009), 50–80% of M&As fail 
because of clashing corporate cultures, a lack of clear communication, and a lack of 
employee involvement in the change. However, employee response to change in the 
pharmaceutical industry remains understudied and underrepresented. Therefore, the 
problem addressed by this study was a lack of scholarly research and understanding of 
the factors that predict employee response to large-scale organizational change such as 
M&As in the pharmaceutical industry.  
Purpose of the Study 
The purpose of this quantitative, correlational study was to narrow the knowledge 
gap on large-scale organizational change in the pharmaceutical industry by evaluating 
key predictors of employee response to large-scale change. The two primary dependent 




of reactions ranging from active resistance to championing change; and support of change 
(SC), which was also expressed as three separate measures: compliance (CM), 
cooperation (CP), and championing (CH). The four independent variables were initial 
change reaction (ICR), change communication (CHC), involvement in change 
development (ICD), and perceived change success (PCS).  
Research Questions and Hypotheses 
The key research questions and their respective hypotheses were the following: 
1. What is the relationship between RC and the predictor variables ICR, ICD, 
PCS, and CHC? 
H01: No relationship exists between RC and the predictor variables ICR, 
ICD, PCS, and CHC. 
Ha1: A relationship exists between RC and the predictor variables ICR, 
ICD, PCS, and CHC.  
2. What is the relationship between SC and the predictor variables ICR, ICD, 
PCS, and CHC? 
H02: No relationship exists between SC and the predictor variables ICR, 
ICD, PCS, and CHC. 
Ha2: A relationship exists between SC and the predictor variables ICR, 




Theoretical Framework for the Study 
The theoretical basis for this quantitative, correlational survey study consisted of a 
synthesis of transformational leadership, stakeholder theory, and change management 
theory.  
Transformational Leadership Theory 
Burns (1978) defined transformational leadership as a relationship between 
leaders and followers wherein they “raise one another to higher levels of morality and 
motivation” (p. 20). Bass (1985) further defined transformational leadership as the 
process through which leaders inspire and motivate people based on collective purposes. 
Bass also noted that transformational leaders are concerned with a follower’s intellectual 
stimulation, while leading through charisma, inspiration, and motivation.  
Wang and Rode (2010) studied transformational leadership as a way to effectively 
lead change. According to Wang and Rode, transformational leadership involves 
encouraging, facilitating, and accepting subordinate interests and input relating to 
organizational concerns and decision-making processes. Similarly, Jaros (2010) found 
that effective change leadership is crucial to planning, implementing, and managing 
successful organizational change. 
Stakeholder Theory 
Freeman (1984) developed stakeholder theory to describe how to address the 
interests of each stakeholder without unfairly valuing some stakeholders over others. 
Freeman defined stakeholders as key players or those with stakes in an enterprise, such as 




This theory was developed for use in establishing equity in value creation, trade, ethics, 
capitalism, and management's role in dealing with those issues. 
Change Management Theory 
Change management theory falls under the umbrella of social or organizational 
psychology. It incorporates a 3-stage model of the change process in which organizations 
move from a position of stasis into a new position or perspective (Lewin, 1947). These 
stages of change, according to Lewin, involve unfreezing (the undoing of an established 
mindset or approach), actual change (which involves a certain degree of uncertainty 
about the future), and freezing (the establishment of a new mindset or position). 
Researchers, such as Marks and Mirvis (2011), subsequently used Lewin’s theories of 
change and group dynamics in studies of organizational adaptation to change to study the 
relationship between cultural differences and M&A outcomes. In response to large-scale 
organizational change associated with corporate mergers, evolving business 
environments, and increasingly globalized markets, studies began to emerge on how to 
manage adaptive and organizational change, some of which used change management 
theory as the theoretical framework. Ruta (2005), for example, demonstrated the use of 
change management theory in implementation of systems in a multinational corporation. 
Nature of the Study 
This quantitative, correlational study was designed to explore employee responses 
to large-scale organizational change such as M&As. It specifically investigated whether 
employees support or resist such change in the context of the pharmaceutical industry. I 




experienced large-scale organizational change. I collected data from these participants 
using the BSCS and additional, pharmaceutical industry-specific questions; the survey 
was administered online, and the survey data analyzed using multiple regression analysis 
to measure associations between BSCS factors and change response. Permission to use 
the BSCS instrument is in Appendix A. I conducted one linear regression analysis for 
Hypothesis 1 and four analyses for Hypothesis 2 (one for each of the individual subscales 
for support of change and one for the composite index).  
The two primary dependent variables in this study were (a) RC on a 9-point 
continuum ranging from active resistance to championing change; and (b) SC, comprised 
of three subscales:  CM, CP, and CH. Each of the subscales is a dependent variable for 
Research Question and Hypothesis 2. For these dependent variables, participants 
answered the support of change items associated with each subscale on a 7-point Likert-
type scale. I then calculated the mean of these subscale responses and combined them 
into a single, composite index that indicates their overall support of change. 
The independent or predictor variables were the four predictors hypothesized to 
affect the change’s implementation: ICR, ICD, PCS, and CHC. To answer the key 
research questions and test the respective hypotheses, I measured the association between 
the dependent variables and the four predictor variables.  
Definitions 
The following key terms and definitions were used in this study: 
Active Resistance: Opposing the change through clear and deliberate actions 




Championing: An extreme enthusiasm for change and doing more than is 
formally required to ensure change success, and promoting the change to others 
(Herscovitch & Meyer, 2002). 
Change communication: The manner and frequency that management conveys 
information relevant to the proposed change to employees (Herscovitch & Meyer, 2002). 
Change communication involves the clarity and quality of communication (good, poor) 
as well as frequency (often, infrequently) of communication. In this study, change 
communication was measured by averaging the responses to two survey questions related 
to communication, creating an overall communication score. 
Compliance: Demonstrating minimum support for change by acquiescing to 
change, but doing so reluctantly (Herscovitch & Meyer, 2002). 
Cooperation: Demonstrating support for change by putting forth effort in change 
initiatives and being willing to make modest sacrifices (Herscovitch & Meyer, 2002). 
Initial reaction: Participants’ responses when first learning about organizational 
change as either negative or positive, ranging from: I will lose my job (negative) to I will 
get promoted (positive) (Herscovitch & Meyer, 2002). 
Involvement in change design: The degree to which an employee takes part in the 
planning and implementation of change (Jaros, 2010). I measured this variable from a 
single survey question. The range of involvement on this item runs from very involved to 
not involved. Employees may be heavily involved in change design to the degree that 
they willingly cooperate, or even champion the proposed change, or employees may be 




Leadership: A series of transactional events between someone in a position of 
authority and their subordinates, or a process in which an individual influences a group of 
individuals to achieve a common goal (Bass, 1990). 
Management: Allocation and utilization of people and their skills to accomplish 
goals. It is “working with and through other people [in organizational settings] to 
accomplish the objectives of both the organization and its members” (Montana & 
Charnov, 1993, p. 1). 
Passive resistance: Subtle, inconspicuous actions intended to oppose a change 
(Herscovitch & Meyer, 2002). 
Perceived change success: The degree to which employees perceive a proposed 
change as completely and effectively implemented (Goksoy et al., 2012). In the context 
of this study, this was a study variable measured by a single survey question for which 
employees chose their agreement on a scale from a complete failure to a resounding 
success. 
Assumptions 
I assumed that all of the participants involved in this survey had a clear 
understanding of and appreciation for the purpose of this study and provided honest, 
forthright answers. I supported this assumption by assuring participants of the strict 
confidentiality and anonymity of the data and information gathered. I also assumed that 
the methodology for this study was reliable and valid, and that the methods of data 




Jolley’s (2001) discussion of research methods and the appropriateness of the quantitative 
design I employed to answer the research questions. 
Scope and Delimitations 
The scope of this study was limited to pharmaceutical industry employees in the 
United States who experienced large-scale change, such as M&As. Although the change 
experiences may be similar in other industries, the data may not be generalizable outside 
of the pharmaceutical industry. Therefore, readers need to interpret the results with 
caution. 
Limitations 
The study could have been limited by the time allocations and cost of resources 
required for the study. The study could also have been limited by the level of efficiency 
in collecting and analyzing data; it could have been limited by the level of validity and 
reliability in analyzing and reporting data, as well. Participants’ willingness to disclose 
information about their perceptions of change and their work environment could have 
also limited the study. In addition, several limitations are inherent within the scope of any 
quantitative study. Foremost, I used a quantitative method to address the research 
questions and hypotheses, but was not able to examine adequately the depth and 
underlying detail of some responses. For example, I did not examine those responses 
related to the perceptions of all aspects of the change’s implementation as they affect a 
participant’s support of the change, and how participants viewed their experience of the 
change or what could have been done better. Thus, my study reflects a trade of a degree 




occur by chance alone, and an ability to examine the numerical change in these 
associations, in accordance with Mitchell and Jolley’s (2001) guidelines. 
Significance of the Study 
Significance to Theory 
The significance of this study lies primarily in its potential to contribute to the 
main mission of the pharmaceutical industry: meeting present and future health and 
pharmaceutical needs of customers, more effectively realized if managers and change 
leaders successfully execute inevitable large-scale organizational change. For example, a 
new medical innovation, such as a cervical cancer vaccine, can result in radical changes 
to a country’s health policy. Additionally, successful change execution can generate 
profit and create jobs. Still, scholarly research on large-scale organizational change in the 
pharmaceutical industry from an employee-response perspective is virtually non-existent. 
This study, therefore, is not only practically significant for pharmaceutical companies 
managing change but theoretically significant as well, since it has the potential to add to 
the research literature. 
Significance to Practice 
A key driver of the significance of this study is the potential to avoid one of the 
common negative outcomes of change: the costly consequence of losing talented 
employees. In a study of employee turnover, Tracey and Hinkin (2008) noted that 
turnover is costlier for higher complexity jobs, such as those in the pharmaceutical 
industry, than for lower complexity ones. Based on data from the Bureau of Labor 




turnover, averaged for all sectors, at close to $14,000 per employee. O’Connell and Mei-
Chuan further illustrated the potential magnitude of this problem by presenting data, 
which showed that the majority of the 24% of employees who quit their jobs annually did 
so voluntarily. In the example O’Connell and Mei-Chuan shared, the annual cost of 
employee turnover at a company with 1,000 employees is over two million dollars. 
Larger pharmaceutical companies typically employ 10,000 to 100,000 individuals. 
Therefore, in addition to contributing to the creation of a supportive work environment 
where employees can operate at their full capacity, a study such as this has significant 
potential to contribute to cost reduction associated with change-related employee 
turnover.  
Large-scale change initiatives, if executed well, can reinforce an employee’s 
commitment to their work and organization. This study is significant because it may 
uncover steps pharmaceutical companies can take to minimize distractions during the 
inherent discontinuity of organizational change, effectively allowing employees to focus 
on executing their work-related responsibilities. This study, therefore, may uncover 
useful information not only for clinical professionals, but also for other stakeholders—
owners, patients, communities, and government. 
Significance to Social Change 
Clinical research professionals at pharmaceutical companies are very much 
involved in creating positive social change. Besides creating profit, the intent of a 
pharmaceutical company’s R&D efforts is frequently to create medicines that meet health 




medicines and other scientific innovations are lifesaving, which is the ultimate testament 
to the potential effect of the company’s work on social change. Given the substantial 
opportunity for social change in this profession, it is important for socially responsible 
organizations to create an environment in which pharmaceutical employees can have the 
greatest effect on others. The study is significant because it may uncover strategies 
organizations can utilize to improve acceptance and support of sound change in the 
pharmaceutical industry. 
Summary 
In this chapter, the focus was on large-scale organizational change in the 
pharmaceutical industry, with particular emphasis on employee response to change. I 
established, through a thorough review of the literature, that limited scholarly research of 
this phenomenon exists, and adapted the BSCS with pharmaceutical industry-specific 
questions to conduct the analysis through a survey. I also listed a number of hypotheses 
to help assess the associations between four predictor variables (ICR, ICD, PCS, and 
CHC) and employee response to change, as measured through two primary dependent 
variables (RC on a continuum ranging from active resistance to championing change; and 
SC operationalized through the level of compliance, cooperation, and championing of 
change).  
Chapter 1 was a succinct review of the key elements of the study and constituted 
the foundation to build on in future chapters. Through a synthesis of transformational 
leadership theory, stakeholder theory, and change management theory, I established the 




limitations in Chapter 1. Chapter 2 examines these three theories in more depth, including 
an explanation of how other researchers used these theories. I further construct a logical 
argument laying out the rationale for this study with emphasis on key drivers of 
pharmaceutical industry change, the expensive and high risk nature of the industry, and 
the potential contribution to positive social change. In Chapter 3, I provide a detailed 
description of the methodology to select research participants, collect, and analyze the 




Chapter 2: Literature Review 
This quantitative, correlational study was designed to measure employees’ 
responses to large-scale organizational change within the pharmaceutical industry. While 
researchers such as Goksoy et al. (2012) and Oreg and Sverdlik (2011) studied employee 
response to change in other industries, this phenomenon has not previously been explored 
in the pharmaceutical industry. The study of change management and employee response 
to change is crucial in the pharmaceutical industry, which is subject to large-scale 
organizational change caused by federal regulations, market trends, and M&As (Hornke 
& Mandewirth, 2010; Mehralian & Shabaninejad, 2014; Saranga & Banker, 2009; 
Vernon, Golec, & Stevens, 2010).  
This chapter consists of a review and synthesis of relevant literature and studies. 
The objective of this review was to critically analyze current change management 
literature on employee response to change, with the aim to identify and describe a gap in 
scholarly research on this phenomenon in the pharmaceutical industry. This review is 
framed by a theoretical framework consisting of change management theory, stakeholder 
theory, and transformational leadership theory, which are also examined in detail. I 
further investigate the overall context of this study by reviewing studies on employee 
support of and involvement in organizational change, and the major drivers of change in 
the pharmaceutical industry. 
Literature Search Strategy 
I obtained the literature for this review through comprehensive online search 




pharmaceutical merger, pharmaceutical industry change, effect of change on employees, 
employee response to change, large-scale pharmaceutical change, management and 
change, and leadership and change. I primarily used Academic Search Complete and 
Business Source Complete to search for relevant and current, peer-reviewed journal 
articles, five or fewer years old. I also searched Walden University’s online library using 
Google Scholar to obtain additional full-text articles for this review. Finally, I obtained 
the titles of several additional studies listed in the bibliographies of key studies on 
organizational change. 
Theoretical Framework 
Change Management Theory 
Change management theory falls under the umbrella of organizational and social 
psychology and is associated with Lewin’s (1947) ideas on change processes and group 
dynamics. Lewin, who is often recognized as the founder of social psychology, 
developed a 3-stage model of the change process that describes moving from a position 
of stasis into a new position or perspective. These stages of change consist of unfreezing 
(the undoing of an established mindset or approach), actual change (which involves a 
certain degree of uncertainty about the future), and freezing (the establishment of a new 
mindset or position). Researchers, such as Marks and Mirvis (2011), later used Lewin’s 
theories of change and group dynamics in studies of organizational adaptation to change.  
In response to large-scale organizational change associated with corporate 
mergers, evolving business environments, and increasingly globalized markets, studies 




utilized change management theory to study implementation of a human resource system 
at various subsidiaries in a multinational corporation. More recently, Deeg (2009) noted 
that because of its ubiquity and inevitability, large-scale change represents potential 
organizational discontinuity and, consequently, effective change management has 
become a major component of organizational success. The pharmaceutical industry is 
especially subject to organizational discontinuity related to large-scale change (Hornke & 
Mandewirth, 2010; Mehralian & Shabaninejad, 2014; Saranga & Banker, 2009; Vernon 
et al., 2010). Therefore, examining studies on change management were appropriate for 
contextualizing and framing this study. 
Transformational Leadership Theory 
Transformational leadership is often associated with successful major change. 
Burns (1978) defined transformational leadership as a relationship between leaders and 
followers wherein they “raise one another to higher levels of morality and motivation” (p. 
20). Bass (1985) also defined transformational leadership as the process through which 
leaders inspire and motivate people based on collective purposes. Wang and Rode (2010) 
studied transformational leadership as a way to effectively lead change. According to 
Wang and Rode, transformational leadership involves encouraging, facilitating, and 
accepting subordinate interests and input relating to organizational concerns and 
decision-making processes. Similarly, Jaros (2010) found that effective change leadership 
is crucial to planning, implementing, and managing successful organizational change. As 
a bottom-up approach, transformational leadership has the potential to engage employees 




demonstrated that employee engagement is a key factor in implementing successful 
organizational change. Therefore, transformational leaders often bring about desired 
effects through inspirational motivation, personal charisma, and by considering and 
motivating followers. 
Stakeholder Theory 
Stakeholder theory was also used as part of the theoretical framework for this 
study. Researchers generally credit the origins of stakeholder theory to R. Edward 
Freeman’s 1984 foundational text Strategic Management: A Stakeholder Approach. 
According to Freeman, stakeholder theory is concerned with issues involving key players 
or those with stakes in an enterprise (i.e., stakeholders): employees, owners, financiers, 
customers, communities, competitors, and government entities. Freeman used this theory 
to question the traditional idea that one stakeholder (such as an owner) is automatically 
more valued than all others are. In a business environment where the main motivation is 
to make a profit, owners (including shareholders) have been seen as the primary 
stakeholder, and many business decisions are made based on the interests of this 
particular stakeholder. However, Freeman argued that the interests and concerns of other 
parties involved, with stakes in an enterprise, should matter as well when making 
business decisions. According to the theory, this inclusive approach creates ownership 
and a sense of belonging for those involved. Like transformational leadership, 
stakeholder theory relies on a bottom-up approach that has the potential to engage crucial 




Key Variables and Concepts 
Employee Involvement in and Support of Change 
Employee commitment to and support of change has been the subject of extensive 
research. Lau and Woodman (1995) examined the causes rather than the consequences of 
change commitment. Jaros (2010) and Whelan-Berry and Somerville (2010) asserted that 
effective organizational change management is crucial to how organizations successfully 
handle large-scale change, and employee participation in and support of change are key 
factors in successful change initiatives. Jaros (2010) also found that getting employees to 
commit to new procedures, policies, and goals involving change increases the likelihood 
of change success. This commitment implies that employees will support the change. 
Employee response to change is multidimensional. It involves behavioral and 
attitudinal components (Jaros, 2012) as well as emotional ones (Mishra & Bhatnagar, 
2010), including feelings of ambivalence (Oreg & Sverdlik, 2011). Therefore, I 
approached employee involvement in change as a multidimensional construct, similar to 
the approach Herscovitch and Meyer (2002) took. According to Herscovitch and Meyer, 
Compliance, cooperation, and championing encompass the range of employee support 
from minimal support of change to enthusiastic promotion or championing of change; the 
negative aspects of response to change, active and passive resistance, complete the 
continuum of reaction to change. 
Recent studies have shown that the manner and the degree to which employees 
are included in change implementation enhances their organization’s successful transition 




explore change management at a traditional print-based global publishing company fully 
preparing to embrace digital-age publishing and to implement changes relating to online 
publication and delivery systems. Franckeiss found that preparing employees for the 
change through hands-on inclusion techniques caused them to support change 
implementation and increased the change success. The inclusive, hands-on techniques 
examined included workshops on leading, implementing, and experiencing the dynamics 
and expectations of change, as well as pre- and postevent webinars with follow-up 
activities. Although Franckeiss’s study was qualitative and examined a different industry, 
it had important implications for this research because it showed that employee 
involvement and inclusion in organizational change increases support for and successful 
implementation of change. 
Researchers and practitioners have also studied and devised formalized 
approaches to change management in recent years, also highlighting the importance of 
employee involvement. For example, Goksoy et al. (2012) studied business process 
reengineering (BPR) as a strategic tool for managing radical organizational change 
intended to improve an organization’s performance. According to Goksoy et al., BPR is 
“the fundamental rethinking and redesign of business processes to achieve dramatic 
improvements in critical, contemporary measures of performance, such as cost, quality, 
service, and speed” (p. 92). High-profile corporations such as Taco Bell, Kodak, IBM 
Credit Corporation, and Hallmark have successfully employed BPR to improve their 
existing business conditions and maintain a competitive advantage. Because BPR has 




BPR as a prominent management trend for organizational change as it applied to a 
multinational electronics and electrical equipment company in Turkey. Goksoy et al. 
empirically analyzed survey responses of 155 employees and found that the key success 
factors of BPR included (a) proper and careful implementation, (b) commitment and 
support from management in terms of resources and leadership, (c) communication, (d) 
teamwork, and (e) adherence to the overall reengineering or change strategy. The 
Cronbach Alpha Internal Consistency Co-efficient came out to 0.8768, indicating that the 
reliability and internal consistency of their five-point Likert scale consisting of 10 
variables were high. The researchers recommended collection of information from 
management and change agents, as well as employees, to obtain accurate information 
about BPR. Although the researchers focused on a global electronics company, the issues 
addressed are applicable to the pharmaceutical industry as well. For example, product 
lifecycles in electronic companies may be short, but pharmaceutical companies must 
constantly focus on innovation because of the long development timeline needed to bring 
medicines and therapies to consumers. Therefore, pharmaceutical companies may need to 
adopt BPR practices to improve operational processes so they can maximize patent life to 
recoup drug discovery and development expenses for profit. Also relevant to my study is 
that the researchers also found employee involvement in the change process through 
teamwork and change communication to be key success factors of change management. 
Change Communication 
 Communication is an integral part of organizational change, as it is the means of 




and Whelan-Berry and Somerville (2010) found that clear communication of change is a 
key component of effective and successful change. Goksoy et al. (2012) found that 48% 
of employees surveyed perceived communication with them before and during BPR 
change implementation to be the overriding success factor of BPR change. In their review 
and analysis of recent organizational change literature, Whelan-Berry and Somerville 
(2010) found that communication was the most identified variable associated with both 
change success and failure. Whelan-Berry and Somerville found that positive 
communication is linked with successful change, and poor communication led to change 
failure. They also noted that regular and clear communication was important throughout 
the entire change process, starting even before initiating the actual change process. 
Whelan-Berry and Somerville further stated that employees’ understanding of the need 
for change in the first place was crucial, as was communication on both individual and 
group levels throughout the change process. In addition, Whelan-Berry and Somerville 
found that good communication was important for both employee adoption and support 
of change. 
Other Key Concepts  
The role of change leaders and human resources. Change leaders might 
overlook the resource requirements and monitoring needed during change 
implementation. In their theory-building meta-analysis, Whelan-Berry and Somerville 
(2010) examined the link between major drivers of change and the organizational change 
process. The researchers observed that while change leaders of an organization may have 




ready for change. They further observed that change leaders often did not consider how 
they might measure successful change afterward. Whelan-Berry and Somerville 
contended that while organizational change can be challenging and complex, it is also 
mapable and foreseeable. Whelan-Berry & Somerville isolated four key contributors to 
successful change: (a) a clear vision of change; (b) leaders’ change-related actions; (c) 
change-related communication, training, and employee participation; and (d) aligned 
human resources practices and organizational structure and processes. Their theory-
building article contributed to the research literature by identifying major factors of 
change and discussing how they relate to the change process in order to manage 
organizational change more effectively. Furthermore, Whelan-Berry and Somerville 
found that adequate change planning is crucial for successful change, and that many 
change efforts fail from lack of adequate resources and planning. They also concluded 
that it is important to use a mix of change drivers across the key steps of the change 
process. This article is important and relevant to my study because it has a link 
demonstrating that employee participation in change is a key factor in effective and 
successful change management, although none of the settings involved the 
pharmaceutical industry. 
Researchers have also studied the key roles that human resource managers can 
take on as change agents in change implementation and management. For example, using 
a mixed-methods case study approach grounded in Gidden’s structuration theory, Barratt-
Pugh, Bahn, and Gakere (2013) studied organization change associated with the merger 




exemplified how human resources departments facilitated and managed change 
implementation through various mechanisms. The researchers conducted the study in 
three phases, starting with a survey of 2,000 employees and ending with interviews of 
employees and of 30 state government executives. Managers used various formal and 
informal agents of change techniques to encourage support for change. The researchers 
found that the mode of change management influenced employee experiences of change: 
positive experiences resulted from informal, relational techniques, while negative 
experiences largely resulted from more formal, authoritative managerial techniques. The 
state departments had selected human resource managers based on technical expertise 
rather than on relational skills, so when change arrived, managers did not have the 
relational or teambuilding skills to effectively usher their teams down new paths. 
Consequently, Barratt-Pugh et al. recommended that human resource departments take a 
strategic approach to change, one that facilitates change by supporting teamwork as 
organizations work through change and emphasizes relational leadership capabilities in 
human resource managers in addition to formal technical skills. Like the findings of 
Goksoy et al.’s 2012 study, the findings of Barratt-Pugh et al.’s study suggested that 
employee involvement in the change process through teamwork was a key success factor 
of change management. Furthermore, the study had valuable practical information on the 
kinds of informal relational skills needed by human resource managers to manage 
effective organizational change. 
The role of transformational leadership. Researchers have studied the 




organizational innovation. For example, in their correlational study, Charbonnier-Voirin, 
El Akremi, and Vandenberghe (2010) hypothesized that transformational leadership is 
the type required to facilitate individual adaptive performance, as well as a climate of 
organizational innovation through teamwork. The researchers recognized that 
transformational leadership may work on both individual and team levels. They used 
hierarchical linear modeling to analyze data collected from 120 employees and managers 
of an aerospace industry organization. Their findings confirmed their predictions that a 
positive link exists between transformational leadership and individual adaptive 
performance and a climate of team-level innovation. Practical implications included 
developing leadership practices that encourage self-management and fosters acceptance 
of team-based decision-making and group goals. 
Researchers also examined transformational leadership and follower creativity as 
they relate to organizational climates of innovation and change. Wang and Rode (2010) 
looked at transformational leadership in relation to how well employees identified with 
their leadership and how supportive of innovation the organization was in relation to its 
employees. They found that the interaction of all three parameters (leadership style, 
climate of innovative, and identification with leader) fostered employee creativity. The 
researchers focused on a large number of organizations across multiple industries, 
including pharmaceutical companies. Pharmaceutical company employees must follow 
strict protocols to comply with a multitude of regulations associated with research 
involving human subjects. However, tremendous room exists for creativity and 




change management practices that support the interaction of these three elements could 
have a positive effect on employee reaction to change in the industry. There remains an 
opportunity to optimize change management effects in an innovative, transformational 
leadership environment, where employees identify with leaders. 
Researchers have also studied transformational leadership as it relates to change 
management in areas related to the pharmaceutical industry, such as nursing. In one 
example, Ricke-Kiely and Robey-Williams (2011) explored how transformational 
leadership could be used to guide and manage change at a South Carolina hospital. The 
researchers used a qualitative research design to gain insight from a sample of nurses 
during a Magnet recognition program, which ran from 2003 to 2005. Magnet recognition 
was a credentialing status designed to attract, recruit, and retain quality nurses. Thirty-
five nurses participated in focus groups. Of the 35 nurses, six were managers, 34 were 
female, and one was male. Over half of the participants achieved at least a bachelor of 
science in nursing degree and the median experience of the group was 20 years. The 
researchers based their theoretical framework on Kotter’s (1996) change model and the 
attributes of transformational leadership. Three major themes concerning the perceived 
change of the hospital emerged from analysis of the data collected: recognition, 
resources, and culture. All participants were aware of the prestigious value of the Magnet 
award, and they all identified recognition as the primary result of it. However, nurse 
managers and staff disagreed on resources. Managers thought the hospital had become a 
more attractive place to work resulting in less over-time expenses, while staff thought the 




noticeable, as staff expected something radical to happen that did not happen, while nurse 
managers saw incremental change associated with research, retention, and increased 
overall quality. Although the study provided valuable information on how employees of 
differing levels perceive change and its consequences, a key limitation of this study was 
that other important stakeholders, such as patients, physicians, and family members, were 
not included in the sample. These stakeholders could have provided useful insight about 
their experiences and perceptions of change. Additionally, a pre-Magnet survey would 
have also served as a good baseline comparison. 
The role of change management. Change is a staple in today’s organizations. 
According to Jaros (2010), as markets became more global, competitive, and de-
regulated, change has become the norm for many organizations and businesses. Jaros 
observed that the globalization and de-regulation of markets, for example, require 
competitive and strategic adaptability on the part of businesses and organizations, 
adaptability that often necessitates the implementation of new goals and change 
initiatives. More and more, organizations must respond to dramatic changes in operations 
and structure, such as those resulting from M&As, in order to remain viable and 
competitive (Deeg, 2009; Hornke & Mandewirth, 2010). In this regard, the 
pharmaceutical industry, in which M&As are seen as essential strategic maneuvers 
(Shibayama, Kunihiro, & Kimura, 2011), is no exception. Furthermore, laws and 
regulations involving medicines also affect change in the pharmaceutical industry 
(Vernon et al., 2010; Whelan-Berry & Sommerville, 2010). Consequently, research on 




increasingly important according to Deeg (2009), Jaros (2010), and Whelan-Berry and 
Sommerville (2010). Although researchers have studied organizational change, change 
management, and employee response to change in the business sector for the past 20 to 
25 years, work on organizational change, change management, and employee 
involvement in change has only recently begun to emerge in relation to the 
pharmaceutical industry. Budhwar et al. (2009), Jaros (2010), and Whelan-Berry and 
Sommerville (2010) are examples of researchers who have done work in the industry. 
Therefore, I will review current peer reviewed studies on change management outside the 
pharmaceutical industry and discuss how they relate to my study on large-scale 
organizational change in the pharmaceutical industry. 
Based on recent research, the change management history of an organization and 
its employees’ previous experiences of organizational change affect future change 
management and change implementation. Bordia, Restubog, Jimmieson, and Irmer 
(2011) observed that change management research has, for the most part, overlooked the 
role of an organization’s change management history in shaping employee attitudes. The 
researchers studied the effects of prior change management on employees’ attitude 
toward change and proposed that prior experience with change influences how employees 
react to new changes. They also proposed that individual change-related experiences and 
the organizational change history of an organization would have significant consequences 
for developing change-related attitudes in employees. In their correlational study, Bordia 
et al. hypothesized that an organization’s poor change management history (PCMH) 




cognitive model, confirmed that prior change experience influenced employees’ reaction 
to change. Findings from interviews and surveys of employees of a Philippine property 
and development firm confirmed Bordia et al.’s hypothesis that employees who 
experienced poor change management in the past are inclined to react poorly to new 
changes. More specifically, the researchers found that PCMH led to decreased openness 
to change, job satisfaction, and trust, as well as to increased cynicism and turnover 
intentions. The findings of this study have significant implications for the pharmaceutical 
industry. The frequency of organizational change in the pharmaceutical industry suggests 
that there is a good chance pharmaceutical employees and companies have experienced 
or will experience change, making the consideration of PCMH on individual and 
organizational levels important to change implementation and management.  
Understanding of organizational change and employee response to it remains an 
area for further study, especially in the pharmaceutical industry. Deeg (2009) observed 
that although change was receiving greater critical and scholarly attention, limitations and 
deficits in the conventional discourse on organizational change were still present. 
Limitations and deficits in the discourse included lack of theoretical sophistication, lack 
of realism, and lack of integration. Deeg argued that existing understandings and models 
of change posit change as incremental and gradual, wherein organizational response is 
modelled on adaptation and reaction. Current discourse on change also often 
characterized change as malleable and predictable, rather than more realistically as 
volatile, sharp, sudden, and radical. Furthermore, Deeg’s study of organizational change 




dispersed discourses leading to difficulties in finding what theories, concepts, and models 
might have in common. To address these limitations, Deeg forwarded a comprehensive or 
integrated model of organizational discontinuity, an approach that encompassed various 
research directions and provided a framework that better mirrors the complexity and 
plurality of organizational discontinuity. For Deeg, this integrated approach did not 
necessarily translate to mere eclecticism, but allowed various theories and insights 
through its inclusive character to find their place in the broader scheme systematically. 
Deeg’s contribution was highly theoretical, and researchers and practitioners have yet to 
test his theory or put it into practice. 
Others have examined change in complex, less-structured environments. Pellissier 
(2011) discussed the complex nature of innovation and change management from an 
organization’s perspective, specifically when implementing change in complex systems 
such as those of developing economies. Like Deeg (2009), Pellissier (2011) noted that 
linear change solutions inevitably missed the mark because it is difficult to predict 
outcomes with so many variables involved. Pellissier argued that developing economies 
require non-linear solutions more so than mature economies because the nature of and 
interplay between variables in developing economies are more unstable. Additionally, the 
organic nature of competition (wherein change associated with competition is taken as 
the norm and accepted as practice) calls for non-linear solutions. Pellissier advanced the 
concept of resilience engineering as a nonlinear innovation model that went beyond 
simply reporting data to delivering insights and projections that support innovation in 




(2009), Pellissier’s (2011) contribution was theoretical, and researchers and practitioners 
have yet to test his theory or put it into practice. 
Employees as stakeholders. In short, firms need stakeholders to exist. Parmar et 
al. (2010) and Duckworth (2014) identified employees as integral to a firm’s existence. 
Duckworth argued that seeing employees as stakeholders can help organizations increase 
social responsibility and achieve performance improvement. As stakeholders, employees 
are greatly important to an organization’s sense of social responsibility because 
organizational decisions and actions, including decisions and actions regarding change, 
intimately affect them. Furthermore, stakeholder engagement and identification are keys 
to social responsibility because of issues concerning compensation, employment security, 
and skill development. Consequently, seeing employees as integral to a firm’s existence, 
as stakeholders, may reinforce employees’ participation in change endeavors, which Jaros 
(2010) and Whelan-Berry and Somerville (2010) found is a key factor to successful 
organizational change implementation. In other words, employees may have an interest in 
organizational change not only as employees (how the change will affect their day-to-day 
operations), but also as stakeholders (the overall effect of change on the organization’s 
success and well-being). 
Researchers also recently used stakeholder theory to examine organizational 
change based on the need for organizations to transition to more sustainable paradigms. 
For example, Valente (2010) noted the struggles of moving from a techno-centric change 
management paradigm focused on business behavior to one that is more inclusive, which 




understand why after 14 years of advocacy from management researchers for a paradigm 
shift, the field of management has not been able to shift from a techno-centric paradigm. 
Valente further sought to understand what was required to move toward an alternative 
paradigm. Valente employed critical systems theories to develop a 3-phased process 
model that advocated a more comprehensive approach, which considered the 
interconnectedness of social and economic factors, as well as associated stakeholders of a 
particular business targeted for change. The implications of Valente’s framework are 
twofold. First, it addresses interconnectedness of social, economic, organizational, and 
ecological issues. Second, it recognizes the effects that multiple and diverse agents with 
little authority can have on change. Although the model does not focus on employees, 
researchers can consider employees as an important part of the interconnected network of 
agents that influence change processes.  
Others approached the study of stakeholder theory from the perspectives of social 
capital, sustainability, and trust. For example, Russo and Perrini (2009) investigated the 
differences in approach to corporate social responsibility (CSR) and treatment of 
stakeholders based on the size of the organization (large or small to mid-sized). They 
found that larger organizations focused more on stakeholder theory, while small to mid-
sized organizations focused on building social capital. Russo and Perrini noted that CSR 
has evolved into a service objective of organizations with a genuine interest in doing 
good for the communities in which they operate.  
In a related article, Garvare and Johansson (2010) developed a model to help 




environmental perspective. Their model shifted focus from simply ensuring the 
organization’s product is the best it could be for customers to ensuring a good working 
environment for employees as well. They expanded the stakeholder management concept 
to include not only employees’ concerns, but to limiting damage to the environment in 
which the organization operates as a way to create sustainability, as well. Greenwood and 
Buren III (2010) argued that organizations have an ethical obligation to treat their 
stakeholders fairly, but that less powerful stakeholders are at risk of unfair treatment. 
Greenwood and Buren III discussed the importance of trust in relationships between 
organizations and their stakeholders. They noted that organizations strive to ensure that 
stakeholders, such as board members and investors who make significant contributions to 
the organization’s financial success, are treated well. Other stakeholders, such as junior 
employees whose contributions may not be as closely and directly linked to the 
company’s success, can be neglected, unless the organization is considered trustworthy. 
Greenwood and Buren III’s study has implications for employee involvement in change 
because it suggested that at lower hierarchical levels, important contributions employees 
make to a change’s success may be neglected or may be missed entirely. 
Sustainable organizational change requires a balanced approach that 
acknowledges stakeholder needs. Change that focuses exclusively on the traditional 
bottom line of reducing cycle time and operating cost, while increasing productivity and 
revenue for the business at the expense of stakeholder concerns and social responsibility, 
may not facilitate an organization’s sustainable future (Garvare & Johansson, 2010). 




and managing change, neglects the needs, concerns, and efforts of other stakeholders, 
including employees (Parmar et al., 2010). Organizations, therefore, must consider 
influences beyond the immediate business needs of the organization and commit to a shift 
towards more responsible business practices that balance economic drivers with social 
and environmental objectives, according to Garvare and Johansson (2010). This shift is 
necessary for sustainable development implementation, as organizations focus on the 
system as a whole and not just the manifestations of the underlying business struggles 
(Valente, 2010). Recent studies (Duckworth, 2014; Parmar et al., 2010; Valente, 2010) 
indicate that such a shift has begun, but without consideration of the multiple 
stakeholders and relationships typical of a complex system, this shift to more socially 
conscious change management is not likely to continue. 
Emotional dimensions to employee commitment to change. There appears to 
be an emotional dimension to employee engagement with organizational change. 
Recently, Mishra and Bhatnagar (2010) studied the link between emotional dissonance 
and organizational identification to turnover intention and emotional well-being in the 
Indian pharmaceutical industry. Mishra and Bhatnagar collected data via a questionnaire 
for their correlational study about the emotional conflicts of 486 pharmaceutical 
representatives in the Indian pharmaceutical industry. They characterized this emotional 
dissonance as the difference between the sales representatives’ true feelings and the 
positive expression the representative must display to customers even if the 
representative’s true feelings are negative. Through hierarchical regression analysis, the 




turnover intentions. In addition, they found that an employee’s need to display potentially 
opposite emotions about what they were feeling was a significant source of employee 
dissatisfaction. They also found that organizational identification and commitment were 
not always matters of outright support or resistance, and that organizational identification 
and commitment to change are complex and sometimes ambivalent. However, Mishra 
and Bhatnagar did not conduct the study in the context of large-scale organizational 
change, and focused on organizational identification instead of commitment to change. 
The researchers also did not address whether emotional dissonance of pharmaceutical 
representatives was greater in the Indian pharmaceutical industry compared to those in 
western countries. Nonetheless, the study was important for measuring organizational 
identification in employees in the context of the pharmaceutical industry in general.  
Sometimes employees do not have strong opinions about organizational change, 
and their responses could be misinterpreted. Oreg and Sverdlik (2011) noted that failing 
to consider ambivalence can lead to misrepresentation of employees’ reactions to change. 
In addition, they noted that employee reaction to change is not unidirectional, and 
employees’ feelings about management can influence their reaction to change. For their 
correlational study, the researchers reanalyzed data from three previous studies on how 
employees felt about organizational change and what change agents affected whether 
employees supported or resisted change. Oreg and Sverdlik found that employees can 
both resist and support aspects of the same change and that those employees’ personal 
attitudes toward change interact with their attitudes toward the change agent, which can 




impression of the change agent could still be ambivalent to organizational change. Oreg 
and Sverdlik’s study was important because it found that by accounting for ambivalence, 
researchers could offer more nuanced explanations of employees’ responses to change. 
Drivers of Change in the Pharmaceutical Industry 
Mergers and Acquisitions 
M&As are common in the pharmaceutical industry. Hornke (2010) and Hornke 
and Mandewirth (2010) noted that M&As have become a global phenomenon and 
business strategy pharmaceutical companies increasingly use to gain and sustain a 
competitive advantage. According to Shibayama et al. (2011), M&As are one of the main 
drivers of change in the pharmaceutical industry and are evolving as an essential strategic 
measure. In an industry where heavy investment of time and money is required to bring a 
promising drug from the laboratories to market, pharmaceutical companies engage in 
various business practices to reduce competition (Granier & Trinquard, 2010). According 
to Granier and Trinquard, established pharmaceutical companies often address 
competitive threat by merging with new entrants to the industry. Shibayama et al (2011). 
noted that mergers create significant logistical issues associated with bringing two 
organizations together. Lipworth, Montgomery, and Little (2013) further found that 
mergers have significant effects on practices and procedures that affect employees, while 
Lukkari (2011) found that mergers also affect external considerations, such as customer 
relationship management. These large M&As typically require excellent change 
management implementation to ensure smooth, successful, and cost-effective transitions, 




A merger significantly affects the logistical issues associated with bringing two 
similar organizations together and on practices and procedures that affect employees. 
Budhwar et al. (2009) observed in their study of Indian pharmaceutical firms that not all 
M&As are successful. They focused on the role of the human resource department in 
managing change associated with cross-border M&A processes and why M&As fail. 
According to Budhwar et al., 50-80% of M&As fail because of clashing corporate 
cultures, a lack of clear communication, and a lack of employee involvement in change. 
They noted that the human resources department of both companies involved must be 
responsible for three critical factors: (a) the blending of organizational cultures, (b) 
facilitating effective communication, and (c) involving employees in the change process 
(Budhwar et al., 2009). Using a case study approach, Budhwar et al. examined three 
major cross-border M&As and interviewed senior executives, human resource 
department heads, and team members of the companies involved. The findings of the 
study largely confirmed the findings of the previous literature outlined above. Because of 
this, Budhwar et al. recommended further integrative study of the role of human 
resources departments in all three stages of the M&As process: pre-integration, 
integration, and unification. Budhwar et al.’s study was important for its cross-border 
focus. Because M&As occur on a global scale, study of cultural differences as they 
pertain to organizational operations and employees during change is increasingly 
important. Although this article focused on Indian pharmaceutical companies, it also 





Marks and Mirvis (2011) also studied the relationship between cultural 
differences and M&A outcomes. Marks and Mirvis observed that the top priority in the 
M&A process is getting the financial component of the deal right, while adhering to 
applicable regulatory requirements. In the pharmaceutical industry, the pipeline of 
products is next in the line of priorities, while “softer” cultural issues, noted Marks & 
Mirvis (p. 873) have ranked low on the priority list. Consequently, they created a 
framework that integrated culture as a core consideration in the M&A process. They 
proposed the framework to assist human resources departments in managing issues 
associated with acculturation in the M&A process. For this framework, the researchers 
used change management theory and highlighted the value of organizations devising a 
clear “cultural endstate” (p. 859). The four distinct cultural endstates included (a) 
pluralism (partner companies co-exist), (b) integration (partners blend current cultures 
together), (c) assimilation (one company absorbs the other), and (d) transformation 
(partner companies merge key elements and adopt new norms and values). Marks and 
Mirvis used classic change management theory to propose that human resources must 
unfreeze extant cultural mind-sets to move people toward the desired cultural endstate, 
and then refreeze the desired culture. However, the researchers observed that a company 
should note, early in the M&A process, which entity will take a dominant role in which 
aspects of the merged organization. Such an approach to M&A-related change could fast 





In another study of change, M&A, and organizational culture, Shibayama et al. 
(2011) examined the management of organizational change associated with the case of 
the M&A process of two Japanese pharmaceutical companies, which led to the formation 
of Astellas Pharmaceutical. Shibayama et al. identified that although previous research 
literature focused on M&A cases in Europe and the United States, studies on M&As in 
Asia were less common. For their case study, Shibayama et al. drew on information 
obtained from in-depth interviews of 10 major players involved in the M&A process, 
including members of senior management. The authors found that the merger was 
successful because both companies used a hybrid model of change management that 
employed both a top-down approach led by a core team of managers, as well as a 
bottoms-up approach supported by employees at all levels of the organization, including 
the lowest. They noted that while there were inefficiencies associated with inclusion of so 
many employees at a low level of the organization, the inclusive approach fostered great 
support for the implemented changes. In addition, the chief executive officers (CEOs) of 
both companies established a relationship of mutual trust that they strengthened and 
sustained throughout the merger process. This study, like others (Barratt-Pugh et al., 
2013; Budhwar et al., 2009; Franckeiss, 2012; Goksoy et al., 2012; Marks & Mirvis, 
2011; Whelan-Berry & Sommerville, 2010), also found that employee involvement in 
change is a key factor in implementing successful change.  
Large-scale change needs good coordination, as they typically affect multiple 
departments. In an article on the connection between internal culture change and 




those associated with mergers, affect multiple departments in large organizations, 
requiring a coordinated whole system approach. According to Radwan, this whole system 
approach entails examining the change from multiple angles. First, change managers 
must consider the actual entity requiring change, along with the associated objectives. 
Next, change managers must consider the process of getting from the current state to the 
desired state. Last, change agents must understand the provisions to put in place to 
support these two previous components of organizational change. All this, Radwan 
argued, requires a whole system approach that may obligate significant change to an 
organization’s governance policy. 
Research and Development, Regulations, and Economics 
Pharmaceutical regulations change constantly and the industry must respond. 
According to Whelan-Berry and Sommerville (2010), these regulations are major drivers 
of change in the pharmaceutical industry and include research and development (R&D) 
guidance to industry and the regulation and marketing of new and existing products. 
Changes in drug regulations can affect R&D and marketing decisions, as well as 
organizational responses leading to change, such as M&As, and offering new lines of 
products (Cook et al., 2009). For example, established pharmaceutical companies 
sometimes address competitive threat by producing generic versions of their competitor’s 
products (Granier & Trinquard, 2010). In addition, considering the enormous amount of 
time and money required to bring new drugs to market, pharmaceutical companies must 




effects, according to Cook et al (2009). This balanced approach is a way to mitigate the 
risk of regulation change while remaining competitive. 
The pharmaceutical industry is also sensitive to new laws and can undergo major 
change as a result. Golec et al. (2009) addressed how government regulations, even 
anticipated ones, could dramatically affect R&D activity in the pharmaceutical industry. 
In this article, Golec et al. reviewed the effect of President Clinton’s announcement of 
pharmaceutical price controls through the Health Securities Act (HSA) on stock prices of 
select pharmaceutical firms. Although the act did not actually pass, significant reductions 
in R&D investment and corresponding reductions in stock prices occurred. For example, 
while new drug applications (NDAs) remained steady following the announcement of 
HSA in 1992, the number of new investigational drug applications (INDs) fell sharply 
and leveled off before rising again in 1995, following the rejection of HSA. This meant 
that pharmaceutical companies were afraid to invest in R&D related to innovations. This 
reduction in spending is understandable, as firms count on the expected right to charge 
for the years of risk they take on to discover and develop medical innovations. 
Consequentially, pharmaceutical companies respond quickly to any threats to the 
company’s ability to recoup such investments, as seen in this study. 
Changes in sample size requirements and types of research studies also drive 
change in the industry. Vernon et al. (2010) reviewed the effect of comparative 
effectiveness research (CER) on innovation in light of the Health Care Reform Act. They 
noted that CER is rigorous, and typically involves large samples intended to show that 




resulted in more efficient and cost effective healthcare delivery. Vernon et al. estimated 
the cost of bringing a drug to market at $1 billion, with some estimates even higher, and 
CER usually occurs during phase III clinical trials, where nearly one third of drug 
development expenses reside (Puig-Junoy, 2010; Scheffer & Kaeb, 2011; Vernon et al., 
2010). Such new requirements add to the already high cost of drug discovery and 
development, placing more pressure on pharmaceutical companies to effect change in 
order to perform well in an ever-changing industry. 
Others have examined the high-risk nature of drug discovery and development. 
Cook et al. (2009) reviewed the high cost of drug development and detailed the low 
percentage of potential drugs that actually make it to market. They also discussed the 
potential value of pharmaceutical innovations, such as pharmacogenomics (using 
genomic markers to predict drug response), in not only reducing the cost of drug 
development, but also effectively laying the groundwork for increased revenue from 
longer patent life associated with faster development timelines. The researchers noted 
that a drug could take more than 12 years from initial investment at the discovery stage 
for it to appear on the market and costs over $1.3 billion. Therefore, when a 
pharmaceutical company identifies a promising drug, speed to market becomes a major 
consideration. Furthermore, Cook et al. observed that the size of clinical trials is one of 
the large cost drivers during pharmaceutical development. Since pharmacogenomics is 
based on targeting specific biomarkers, these types of clinical trials tend to require fewer 
patients to demonstrate a statistically significant response, which according to Cook et 




exposed to investigational products. Although the value of this type of innovation is 
promising, the authors did not mention the need to demonstrate a clinically meaningful 
response nor the changes required to adopt this innovation. 
Other Approaches to Understanding Organizational Change 
Researchers have used various frameworks and context to explain organizational 
change. Lau and Woodman (1995) introduced change schema as a construct by which to 
study organizational change. Lau and Woodman defined a schema as a hypothetical 
cognitive structure that represents how individuals organize knowledge about a kind of 
stimulus or a given concept. Lau and Woodman identified three general dimensions of 
individual-level schema from the literature at the time: causality, valence, and inferences. 
Causality is a frame of reference for connecting people and phenomena, a framework for 
attributing causes of behavior to self and others. Valence refers to an individual’s 
evaluation of the significance of an event or a relationship. Inferences enable individuals 
to predict or infer what behaviors or events are likely to occur based on causality 
frameworks. An individual’s schema is based on previous experiences and beliefs that 
help forecast the possibility of events and behaviors. Lau and Woodman based their 
change schema construct on individual-level schema to include a general attitude toward 
change that consisted of locus of control, dogmatism, and organizational commitment. 
The idea was that an individual’s change schema would prove an effective construct to 
predict commitment to change. The researchers sampled 331 students concerning a major 
potential change involving a university tradition of building a massive bonfire during a 




change with an 8-item scale designed to target the factors of an individual’s change 
schema. Using cross-sectional structural equation modelling (SEM), Lau and Woodman 
found that a student’s change schema did significantly and positively predict commitment 
to change (b=.16). The study was important not only for introducing a construct by which 
to study commitment to organizational change but for focusing on antecedents of change 
commitment as well. 
 Researchers have studied employee response to change in the hospitality industry. 
Hartline and Ferrell (1996) studied the management of customer-contact service 
employees of a hotel that was implementing improvements to their customer service 
program. The researchers developed and tested a model of service employee management 
that involved three formal managerial control mechanisms: empowerment, behavior-
based employee actions, and management commitment to service quality. Hartline and 
Ferrell sought to measure the impact the hotel managers’ commitment had on the effort 
they displayed to ensure that customer-contact workers were implementing the planned 
changes in hotel services. The researchers surveyed 797 hotel managers and customer 
service workers in 279 hotel units via an adapted version of the Organizational 
Commitment Questionnaire (OCQ) and found through cross-sectional SEM analysis that 
managers who were committed to service quality were more likely to use behavior-based 
evaluation and to empower their employees. Therefore, managers who were committed to 
change were likely to use these leadership strategies to motivate their subordinates to 




information on organizational change and suggested ways to study the role of 
management in employee commitment to change in service sectors. 
 Herscovitch and Meyer (2002) developed a multi-dimensional construct to study 
commitment to change based on three dimensions: affective (positive feelings toward 
commitment), normative (perceived obligation to comply), and continuance (perceived 
consequences of failure to comply). Herscovitch and Meyer conducted three studies to 
test their three-component model of workplace commitment to change. Study number one 
consisted of 224 graduate psychology students to provide preliminary evidence for 
construct validity; studies two and three involved hospital nurses (N = 157 and 108, 
respectively) from various medical facilities. For these two studies, the researchers 
hypothesized that employees experience three commitment-to-change mindsets (affective 
commitment to change, normative commitment to change, and continuance commitment 
to change) that could predict change-oriented behavior better than organizational 
commitment could. Using hierarchical linear modelling across these two studies, 
Herscovitch and Meyer found that when seen as a behavioral continuum of change-
support actions, commitment to change was a better predictor of behavioral support for 
change than was organizational commitment. More specifically, affective commitment to 
change positively predicted support in both samples, while normative commitment to 
change positively predicted support in one sample and not the other. However, 
continuance commitment to change did not predict change support in either sample. 




The study was important, however, for introducing compelling evidence that researchers 
might effectively study commitment to change as a multi-dimensional construct. 
 In the law enforcement industry, researchers have also been active studying 
change. Ford, Weissben, and Plamondon (2003) examined police officers’ attitudes and 
receptivity to newly implemented changes in community policing procedures and the 
impact of organizational commitment and strategy commitment on commitment to 
change. The researchers hypothesized that managerial support, job experience, and 
organizational commitment would positively influence community policing strategy 
commitment. The researchers collected data from 432 police participants—363 officers 
and 69 sergeants from 11 different police departments and used a modified OCQ as a 
measurement tool. Using cross-sectional SEM analysis, Ford et al. found that managerial 
support, job experience, and organizational commitment did positively predict 
commitment to change, which in turn predicted community policing strategy 
commitment. Consequently, the findings of the study suggested that work experience 
factors, supervisory support, and organizational commitment could be important factors 
of commitment to change strategies. In addition, the study was important for showing 
that organizational and strategy commitment could be conceived as two distinct, albeit 
related, levels of commitment. 
 What distinguished Fedor, Caldwell, and Herrold’s study (2006) was the 
theoretical innovation of approaching organizational change as a multi-level 
phenomenon. The researchers observed that previous studies on organizational change 




consider that change may have different impacts and effects within and across various 
organizational levels (e.g., upper, divisional, managerial, unit). Fedor et al. studied 
individuals’ commitment to the change itself as well as their organizational commitment 
in 34 different public and private organizations. Fedor et al. collected data from 806 
managers and office workers via questionnaires. The researchers posited that both kinds 
of commitment were best approached as a three-way interaction between an individual’s 
favorableness to the change, the extent of change, and the impact of change on the 
individual’s job. To study these variables at the group level, Fedor et al. split their sample 
so that half of the participants who shared the same group-level effects would provide 
group-level data. Fedor et al. used multi-level hierarchical linear modelling and computed 
RWG scores (.90) to assess agreement among group members and ICC coefficients to 
examine how much group membership accounted for individual member ratings to 
ensure group membership reliability. They found that considering change at multiple 
levels was necessary to gain a better understanding of individual employees’ reactions to 
change and concluded that assessments of change at different organizational levels may 
help to explain individual level responses to change.  
 Undesirable employee turnover is an inherit risk in organizational change. 
Cunningham (2006) sought to expand research on organizational change that focused on 
employee cognitions, attitudes, and behaviors by adding consideration of how employees 
cope with change and their turnover intensions. Cunningham operationalized coping as 
employee perception of how well they handled changing circumstances. Cunningham 




normative, and continuance dimensions to study employees’ commitment to change and 
test his hypotheses that coping with change and turnover intentions were related to 
commitment to change. Cunningham (2006) collected data via questionnaire from 299 
employees of 10 National Collegiate Athletic Association (NCAA) programs undergoing 
change initiated by incoming athletic directors. Using cross-sectional SEM, Cunningham 
found that (a) the connection between turnover intentions and affective commitment to 
change was mediated by coping with change, (b) the connection between turnover 
intentions and continuance commitment to change was partially mediated by coping with 
change, and (c) normative commitment to change directly affected turnover intentions. 
Cunningham concluded that affective commitment may increase when employees 
participate in the change process, as involvement helps them cope with change. However, 
the alpha coefficient for the coping with change measure was .63, suggesting that this 
mediating construct was below the customarily acceptable level of reliability. 
 Others have used psychological concepts to explain employee reaction to change. 
Chen and Wang (2007) attempted to assess psychological reactions to change using the 
concept of locus of control in relation to Herscovitch and Meyer’s (2002) ideas of an 
individual’s affective, normative, and continuance commitments to change. Locus of 
control refers to a person’s perception of their ability to exercise control over contextual 
elements of a situation, and individuals are referred to as being either internals or 
externals. Those who consider themselves internal believe they have control over their 
situations (i.e., that the locus of control is within them), and those who consider 




of control resides outside of them). Chen and Wang (2007) surveyed 256 customs 
workers in a service department at a border city in Southern China. The organization was 
implementing a new employee performance review system. Chen and Wang employed 
Herscovitch and Meyer’s (2002) 18-item scale as a measurement tool, and using cross-
sectional hierarchical regression analysis, found that locus of control was positively 
related to affective and normative commitment to change (r = -.22, p < .01; r = -.19, < 
.01, respectively) and negatively related to continuance commitment to change (r = .24, p 
< .01). In addition, those with high internal locus of control showed higher affective and 
normative commitment to change than those with high external locus of control did, but 
those with high external locus of control were higher in continuance commitment to 
change. Chen and Wang (2007) concluded that internals would commit to change out of 
personal desire (affective) or obligation (normative), while externals would commit to 
change because of their perception of the costs associated with failure to support change 
(continuance). The study was important for four reasons: (a) it showed that locus of 
control could predict employees’ commitment to a specific change, (b) it increased 
understanding of the psychological mechanisms through which people with different loci 
of control react to change, (c) the results provided support for Herscovitch and Meyer’s 
model of workplace commitment, and (d) the study extended the three-component model 
of change commitment to a non-Western context. 
Gap in the Literature 
 All these critical studies in the change management literature serve to highlight 




Yet, the settings for these studies were not the pharmaceutical industry. Goksoy et al. 
(2012), Hartline and Ferrell (1996), Oreg and Sverdlik (2011), Seo et al. (2012), 
Stensaker and Meyer (2008), and Tyler and De Cremer (2005) specifically studied 
employee response to change in other industries, including nursing, law enforcement, 
college, sports, and business, leaving a gap in scholarly research on employee response to 
change in the pharmaceutical industry.  
There is a need to narrow this gap, as pharmaceutical research and development is 
the cornerstone of one of the most expensive and high-risk industries and crucial for 
addressing the world’s unmet medical needs. Golec et al. (2010) estimated the cost of 
bringing a drug from discovery to market at $1.8 billion, while Cook et al. (2009) noted 
that only 1 in 10,000 discovered compounds make it to market. In addition, this industry 
frequently engages in M&As, a type of large-scale organizational change. Since 50-80% 
of M&As fail according to Budwar et al. (2009), it is even more important to study this 
phenomenon in such an important and high-risk industry. Budwar et al. cited lack of clear 
communication and a lack of employee involvement in the change among the reasons 
M&As fail. These are among the variables I will examine in this study of employee 
response to large-scale change in the pharmaceutical industry. 
Summary and Conclusions 
Based on this synthesis of the literature, it appears that inclusion of employees in 
organizational change implementation increases their support of change (Barratt-Pugh et 
al., 2013; Budhwar et al., 2009; Franckeiss, 2012; Goksoy et al., 2012; Marks & Mirvis, 




as stakeholders concerned with an organization’s overall success may help establish a 
bottoms-up approach to including employees in the change process (Duckworth, 2014; 
Greenwood & Buren III, 2010). In addition, researchers found that employees can have a 
nuanced reaction to change, that they do not always outright support or resist change 
(Mishra & Bhatnagar, 2010; Oreg & Sverdlik, 2011). Employees can both resist and 
support aspects of the same change, and their personal attitudes toward change interacts 
with their attitudes toward the change agent, which can result in ambivalence (Mishra & 
Bhatnagar, 2010; Oreg & Sverdlik, 2011). Such findings encourage researchers to more 
accurately measure employees’ response to change (Oreg & Sverdlik, 2011). 
Additionally, effective change management also includes clear communication of change 
before and during implementation, as well as employee and organizational change 
histories as other key factors in successful organizational change (Budhwar et al., 2009; 
Goksoy et al., 2012; Whelan-Berry & Sommerville, 2010). As Barratt-Pugh et al. (2013), 
Budhwar et al. (2009), and Marks and Mirvis (2011) demonstrated, the role human 
resources departments and change managers play in successful change and how they can 
facilitate the blending of organizational cultures is key. In addition, transformational 
leadership, an inclusive leadership style that includes the concerns and views of 
subordinates, has proven effective in organizational change because it can include 
employees in the planning and implementation of change (Charbonnier-Voirin, El 
Akremi, & Vandenberghe, 2010; Ricke-Kiely & Robey-Williams, 2011; Wang & Rode, 
2010). Although these studies focused on organizational change and some specifically on 




The major shortcoming is that research on employee support of change in the 
pharmaceutical industry is virtually nonexistent. Given the high stakes nature of the 
pharmaceutical industry (Golec et al., 2010) and the pervasiveness of change in the 
industry (Bordia et al., 2011), such work is clearly needed. In my study, I sought to 
contribute to needed research on employee response to change in the pharmaceutical 
industry. Because employee response to change in other areas of study involves 
behavioral and attitudinal components (Jaros, 2010), as well as emotional ones (Mishra & 
Bhatnagar, 2010), including feelings of ambivalence (Oreg & Sverdlik, 2011), I 
approached employee involvement in change in the pharmaceutical industry as a 
multidimensional construct, similar to Herscovitch and Meyer’s (2002) approach. 
Compliance, cooperation, and championing should encompass the range of employee 
support from minimal support of change to enthusiastic promotion of change, with active 
and passive resistance completing the full spectrum of employee reaction to change. With 
this study, I offer a starting point for future research on employee response to large-scale 
organizational change in the pharmaceutical industry. 
 In Chapter 3, I provide a detailed description of the methodology I used. This 
chapter includes the selection of research participants, the quantitative, correlational 
research design and rationale, population and sampling procedures using 
SurveyMonkey’s participant pool, as well as data collection and analysis. It also includes 




Chapter 3: Research Method 
The purpose of this study was to reduce the knowledge gap in scholarly research 
on large-scale organizational change in the pharmaceutical industry by evaluating key 
predictors of employee response to large-scale change. These key predictor variables 
were ICR, ICD, PCS, and CHC. Using a synthesis of transformational leadership, 
stakeholder theory, and change management theory as the framework, I statistically 
examined which of these variables predicts RC (continuum ranging from active resistance 
to championing) and SC (CM, CP, and CH). RC and SC were the two primary dependent 
variables. CM, CP, and CH (subscales of SC) were also dependent variables. By 
providing information on employee response to change, this study has practical 
implications for pharmaceutical managers and change leaders planning and implementing 
change. 
In this chapter, I outline the methods enacted in the study, as well as the specific 
procedures to test the hypotheses associated with the two primary research questions and 
three additional research questions related to the subscale of SC. This chapter also 
includes acknowledgement of the limitations of the design, and potential issues of 
validity to the study, while giving special regard to methods used to remedy these issues. 
Research Design and Rationale 
I used a quantitative, correlational design in this study. This was the most 
appropriate method because the aim of the research was to examine statistically the 
effects of quantifiable concepts (Howell, 2012). The focus of this research was to 




Each of these variables was measureable through numerical responses to a survey 
instrument. I therefore utilized a research design that allowed for an objective view of the 
variables of interest, and which permitted a relatively higher level of certainty while 
forfeiting the richness of detail associated with qualitative research (Bansal & Corley, 
2011). 
Qualitative research has no standard measures, and instead relies on the 
researcher’s interpretations (Bansal & Corley, 2011).  This would have been an 
appropriate research method if, for example, I was interested in an in-depth exploration 
of the participants' emotional responses to M&As in the pharmaceutical industry. Thus, I 
rejected the qualitative methodology. By contrast, the mixed methods approach requires a 
comprehensive data collection process (Crosbie & Ottmann, 2013; Heyvaert, Maes, & 
Onghena, 2013). This would have required a pilot study followed by the main study, and 
would have involved both quantitative and qualitative methods. Since my focus was on 
determining key predictors, without the need for rich, qualitative details, the quantitative 
method fully satisfied the objectives of my research. Therefore, I rejected the mixed 
method approach as well and utilized a quantitative design. 
Methodology 
My research study followed a correlational approach, which was appropriate 
because the scope of the research was to determine the effect of one or more measureable 
variables on a measureable outcome variable, in alignment with the guidelines provided 
by Creswell (2005). With correlational research, the researcher’s aim is to determine 




formula to express a potential relationship where ICR, ICD, PCS, and CHC, affect RC, 
SC, and the subscales of SC (Mitchell & Jolley, 2001). This approach resulted in five 
regression analyses aligned with the two research hypotheses. The first analysis, 
conducted to test Hypothesis 1, was to predict the continuum of RC, which includes both 
positive and negative reactions, ranging from active resistance to championing change. 
The remaining analyses, conducted to test Hypothesis 2, were to predict SC, 
operationalized through CM, CP, and CH. Measures for ICR, ICD, PCS, and CHC were 
the independent, or predictor variables. 
Population 
The population examined in this research was comprised of pharmaceutical 
industry employees with various years of experience. These individuals worked at 
traditional pharmaceutical companies that discover and develop investigational medicinal 
products (IMPs). The participants also worked at biotechnology companies that discover 
IMPs, but outsource development to contract research organizations (CROs), which were 
also a population of interest. In order to be eligible, the participants must have also 
experienced some large-scale change in their company, such as an M&A, to be included 
in the study sample. This change had to have occurred at their current employer or at a 
previous organization where the participant worked. 
Biotechnology companies, smaller CROs, and small pharmaceutical companies 
have a few to several hundred employees. However, larger CROs can have more than 




employees (Masri, Ramirez, Popescu, & Reggie, 2012). I targeted these and other types 
of pharmaceutical industry employees for my study. 
Sampling and Sampling Procedures 
To gather sample participants from this population, I contacted pharmaceutical 
industry employees who recently experienced a large-scale change using 
SurveyMonkey’s sample selection service. A collector at SurveyMonkey contacted 
employees from qualifying companies who had already provided consent to be contacted 
for surveying, and requested their participation in the study. I instructed SurveyMonkey 
to collect participants based on the following criteria: 
 Participants must have been either employees at pharmaceutical companies, 
including CROs and biotechnology companies, or organizational change experts 
within the pharmaceutical industry.  
 Participants must have had experience with the pharmaceutical industry, though 
varying amounts of experience are acceptable.  
 Participants must have experienced some large-scale change in their company. I 
provided participants with an informed consent statement on the front page of the 
survey, requiring consent to participate in the study before continuing.  
The sampling method used was stratified sampling, because I gathered a 
purposive, targeted sample representing a diverse mix of industry experience and 
inclusion of at least one change expert, as recommended by Howell (2012). This 
approach led to a sample of participants who had previous experience with large-scale 




employee mix at a pharmaceutical company. Through SurveyMonkey’s participant pool, 
I ensured targeting of a diverse sample representing various levels of experience and job 
categories, including change management experts. 
For my study, I used multiple linear regression as the statistical analysis 
technique. Using G*Power version 3.1.9 (Faul, Erdfelder, Buchner, & Lang, 2013), I 
calculated the necessary sample size to achieve empirical validity. For a regression 
analysis with a generally accepted power of 0.80 (Cohen, 1992), an alpha of 0.05, and 
four predictor variables, the multiple linear regression requires a minimum of 85 
participants to detect a medium effect, or f2 = 0.15 (Cohen, 1977; Herscovitch & Meyer, 
2002). I chose a medium effect size as the expected result of a generic statistical finding, 
which is typical when the specific effect size is not well known, according to Faul, 
Erdfelder, Buchner, and Lang (2012). At the time of the survey, the possibility of a 
regression analysis with four predictor variables existed. Thus, to assess a relationship 
with 95% certainty that it did not occur by chance, I sought to assemble a sample of at 
least 85 participants. With only three predictor variables in any one of the linear 
regression analyses performed, the minimum sample size would be 77. Thus, the 
sampling was performed with a conservative approach and any valid samples greater than 
77 would have the effect of simply increasing power and confidence in the hypothesis 
tests. 
To achieve a final sample of at least 85 participants, I sent 170 surveys to 
prospective participants. This sampling frame allowed for a 50% return rate while still 




average response rate for academic studies (Baruch, 1999). If the main sample had not 
met the minimum size of 85 participants, I would have disseminated additional surveys, 
which I did and ended up with 98 completed surveys.  
Procedures for Recruitment and Informed Consent 
I used an informed consent document as the discussion framework for obtaining 
consent from study participants (see Appendix B). In establishing the relationship with 
the study participants, I introduced the study to the participant by explaining the purpose 
of the study, describing the procedures, disclosing the risks and benefits, establishing the 
role of the participant, and estimating the time involved. I informed all participants that 
participation was voluntary. I also informed participants that I would not use any 
identifiable data in the study and that they could drop out of the study at any time without 
penalty.  
Participants in this study received a copy of the informed consent document at the 
front of the survey. This document included the contact information for me, my 
dissertation advisor, and Walden’s IRB (approval number 07-02-15-0136499 with an 
expiration date of July 1, 2016; see Appendix C). I did not allow prospective participants 
to take part in the study without first indicating that they consented to be participants in 
the study. Only those who selected that they read the informed consent document and 
agreed to participate were allowed to continue to the survey questions. Thus, agreement 





For participants who agreed to participate in the study and provided informed 
consent, SurveyMonkey provided a link to the survey. Through the online survey, I 
administered the BSCS (Herscovitch & Meyer, 2002) supplemented with industry-
specific questions, as well as a few questions to better understand the characteristics of 
the population. I labeled participants using a confidential identifier so that their data may 
be identified if they later choose to opt out of the study. I stored data on the survey host 
server until it was time to download and store it on a thumb drive for access and analysis. 
I did not follow up with participants in any way. 
Operationalization of Constructs 
The four independent variables in this quantitative, correlational study were ICR, 
PCS, ICD, and CHC (including considerations of the quality and frequency of 
communication). RC and SC were the two primary dependent variables. RC was 
represented on a continuum ranging from a negative reaction of active resistance to a 
positive reaction of championing change. SC was a composite index computed by 
combining the dependent variables representing the subscales of CM, CP, and CH. The 
following section is a discussion of how I operationalized these variables. 
Dependent Variables 
Reaction to change (RC). The way in which an employee reacts to large-scale 
organizational change fell on a continuum ranging from a negative reaction of active 
resistance to a positive reaction of championing change, represented by a 9-point Likert 




on the continuum on Question 10 of the survey, as represented in Figure 1. The 
continuum of possible responses on the reaction to change continuum. I converted this 
continuum to an index ranging from 0-100, for the sake of consistency among the 
dependent variables, as follows: 
 RC = 12.5 (L) – 12.5 where L = the raw Likert scale response. 
 Thus, I converted a response of 1 to 0, and a response of 9 to 100. 
 
Figure 1. The continuum of possible responses on the reaction to change continuum. 
Support of change (SC). The manner in which an employee supports large-scale 
organizational change involves three levels of support: compliance (CM, 3 survey 
questions), cooperation (CP, 8 survey questions), and championing (CH, 6 survey 
questions). Much like RC, these represent a spectrum of increasing support of a change 
initiative. Participants answered the items associated with each category on a 7-point 
Likert-type scale from the BSCS instrument. I calculated subscales of support as the 
mean of responses to the corresponding survey questions, and each of these subscales 
represented a dependent variable for one test of Hypothesis 2, with the intention of 
capturing detail on each specific facet of support. The instrument’s developers, 
Herscovitch and Meyer (2002), support this scoring scheme, where the specific subscales 
should be measured. Herscovitch and Meyer also indicated that the overall score, taken as 




supported the change overall. Higher scores indicate a greater degree of support of 
change. A composite index for SC was also a dependent variable, with higher values 
indicating greater support of change. SC was simply the average of the converted values 
for the three subscales, CM, CP, and CH, as follows: 
 SC = (CM + CP + CH) ÷ 3. 
Compliance (CM). This construct of support measured the extent to which 
employees accepted a change. This involves how much employees agree to accept role 
changes and adjust their workplace habits to comply with those changes. I measured this 
variable as the mean of Survey Questions 11–13 on the measures of behavioral support 
for change portion of the survey, where higher scores corresponded to greater compliance 
with change. I converted the mean response to a subscale for compliance (CM) that 
ranged from 41 to 60, as follows: 
 CM = 3.167 (LCM) + 37.833 where LCM = the mean Likert response for 
compliance. 
Cooperation (CP). This construct of support measured the extent to which 
employees assisted in changing the company. This construct defined how well employees 
engaged in change-related behaviors, avoided former practices, and tolerated temporary 
disruptions caused by the change. I measured this variable as the mean of Survey 
Questions 14–21 on the measures of behavioral support for change portion of the survey, 
where higher scores corresponded to greater cooperation with change. I converted the 




 CP = 3.167 (LCP) + 57.833 where LCP = the mean Likert response for 
cooperation. 
Championing (CH). This construct of support measured the extent to which 
employees encouraged others to cooperate with and accept the change. This construct 
gauged how actively employees spoke positively about the change, overcame resistance 
to the change, and persevered with the change in order to reach goals. I measured this 
variable as the mean of Survey Questions 22–27 on the measures of behavioral support 
for change portion of the survey, where higher scores corresponded to greater 
championing of the change. I converted the mean response to a subscale for championing 
(CH) that ranged from 81 to 100, as follows: 
 CH = 3.167 (LCH) + 77.833 where LCH = the mean Likert response for 
championing. 
Independent Variables 
The independent variables of the study measured the participants’ perceptions of 
the change’s implementation. These perceptions included initial change reaction, 
involvement in change design, perceived change success, and change communication. I 
measured these through responses to the pharmaceutical industry questions portion of the 
survey. 
Since I developed this portion of the survey, I ran it through a brief field test. For 
this, I targeted three respondents to assess the survey for face validity, and to determine if 




respondents to provide feedback on any areas of the assessment they felt needed 
improvement, with the intent to make changes as appropriate. 
Initial change reaction (ICR). This item asked participants to rank their response 
to first learning about the organizational change as either positive or negative. The range 
of initial reactions ran from “I am going to lose my job” = 1 to “I may get promoted” = 7. 
Thus, lower scores on this variable corresponded with a negative opinion of the change, 
while higher scores corresponded with a positive opinion of the change. I used a single 
survey question to assess this independent variable. 
Involvement in change design (ICD). Involvement in change design refers to the 
degree to which an employee takes part in the planning and implementation of change. 
The range of involvement ran from “not involved” = 1 to “very involved” = 7. 
Employees may be heavily involved in change design to the degree that they willingly 
cooperate, or even champion the proposed change. Alternatively, employees may be 
minimally involved or not involved at all. As such, a higher degree of involvement 
corresponded with higher scores. 
Perceived change success (PCS). Perceived change success refers to the degree 
to which employees perceived the proposed change to be completely and effectively 
implemented. Employees chose on a scale from “a complete failure” = 1 to “a resounding 
success” = 7. As such, higher scores indicated perceptions of an increased amount of 
success.  
Change communication (CHC). Change communication refers to the manner in 




as well as the frequency. Change communication involves the clarity and quality of 
communication, where “Very bad” = 1, and “Very good” = 7. Frequency described how 
often the change was communicated to employees, and ranged from “Rarely” = 1, to 
“Very often” = 7. I calculated the change communication score as the average of these 
two measures. Thus, this variable ranged from 1 to 7, where higher scores corresponded 
with a frequent, high quality level of communication about the change. 
Data Analysis 
I entered data into SPSS version 22.0 for Windows and used descriptive statistics 
to better understand the sample characteristics and the research variables used in the 
analysis. I calculated frequencies and percentages for any nominal (i.e., categorical) 
variables of interest, such as job function and highest level of education completed. For 
any continuous data (i.e., scale or ratio), I calculated means and standard deviations. 
I screened the data for accuracy, missing data, and outliers. I calculated 
descriptive statistics and frequency distributions to determine that responses were within 
a possible range of values, and that outliers did not distort data. I tested for the presence 
of outliers by calculating standardized values. Standardized values represent the number 
of standard deviations an individual score falls from the mean of those scores. According 
to Tabachnick and Fidell (2012), participants with scores more than 3.29 standard 
deviations from the mean are considered outliers, and as a result, that participant’s survey 
should be removed from the data set. Additionally, I examined cases with missing data 
for non-random patterns and excluded participants with large portions of non-random 




After screening the data, I conducted the necessary analyses to test the hypotheses 
and to inform the research questions of interest, restated here for reference. I conducted 
one regression analysis to address Research Question and Hypothesis 1 and four 
regression analyses for Research Question and Hypothesis 2. 
Multiple regression is an appropriate analysis when the goal is to assess the extent 
of a relationship among a set of dichotomous or interval and ratio predictor variables on 
an interval and ratio criterion variable. I used the following regression equation (main 
effects model):  
 ?̂? = β0 + β1X1 + β2X2 + … + βkXk    
where ?̂? = the predicted value for the response variable, β0 = constant, β1 = first 
regression coefficient, β2 = second regression coefficient, βk = k
th regression coefficient, 
and Xi = predictor variables (Tabachnick & Fidell, 2012). I did not assess any interaction 
terms because my goal was not to determine moderating effects of any of the research 
variables. 
1. What is the relationship between RC and the predictor variables ICR, ICD, PCS, 
and CHC? 
H01: No relationship exists between RC and the predictor variables ICR, 
ICD, PCS, and CHC. 
1 = 2 =  = k = 0. 
Ha1: A relationship exists between RC and the predictor variables ICR, 
ICD, PCS, and CHC.  




2. What is the relationship between SC and the predictor variables ICR, ICD, PCS, 
and CHC? 
H02: No relationship exists between SC and the predictor variables ICR, 
ICD, PCS, and CHC. 
1 = 2 =  = k = 0 
Ha2: A relationship exists between SC and the predictor variables ICR, 
ICD, PCS, and CHC. 
At least one j ≠ 0 
Multiple Linear Regression 
To examine the two research questions, test the hypotheses, and assess how well 
the four perceptions of a change predict employee response to change, I conducted two 
sets of multiple linear regressions. The first multiple linear regression tested Hypothesis 
1, assessing the collective effect of the four independent variables (ICR, ICD, PCS, and 
CHC) on RC (Stevens, 2009).  
The next set of three multiple linear regressions tested Hypothesis 2, assessing the 
collective effect of the four independent variables (ICR, ICD, PCS, and CHC) on each of 
the three sub-construct dependent variables individually (CM, CP, and CH) that comprise 
SC (the second of the two primary dependent variables). Following these three regression 
analyses for the support of change, I conducted a fifth and final overall regression. In this 
final regression analysis, I used the same four independent variables, but calculated the 
results using a single dependent variable (SC). This single dependent variable was the 




I used the F test to assess whether the set of independent variables collectively 
predicted the dependent variable. I reported R2, the multiple correlation coefficient of 
determination, and used it to determine how much variance in each dependent variable 
the set of independent variables can account for. I used t-tests within the regression 
model to determine the significance of each predictor and used beta coefficients to 
determine the extent of prediction for each independent variable, while controlling for the 
other included predictors. Regarding significant predictors in the final regression model, 
for every one unit increase in the predictor, the dependent variable was predicted to 
increase or decrease by the unstandardized beta coefficient. 
Prior to analysis, I assessed the assumptions of multiple linear regression. The 
assumptions of multiple linear regression include linearity, homoscedasticity, and 
absence of multicollinearity. Normality assumes that error term in the model is normally 
distributed, while homoscedasticity assumes that error terms have equal variance. I 
assessed normality and homoscedasticity by examination of scatter plots, used a normal 
probability plot to assess normality, and a residual scatterplot to assess homoscedasticity 
(Tabachnick & Fidell, 2012). The absence of multicollinearity assumes that predictor 
variables are not too closely related, and I assessed this assumption using Variance 
Inflation Factors (VIF). VIF values over 10 suggest the presence of multicollinearity and 
a violation of the assumption (Stevens, 2009). 
Threats to Validity 
Causal inference is usually a potential issue regarding internal validity. However, 




Causal inference is only applicable when the cause precedes the effect (Tabachnick & 
Fidell, 2012). In this study, it was difficult to determine that the predictor variables were 
the de facto cause of response to change. In some cases, participants may have been 
supportive of the cause, and inadvertently responded in a more positive manner regarding 
the communication and success. In addition, involvement with the change may have been 
linked with support or a positive reaction because of confounding factors such as 
personal pride. I noted these as limitations, and Creswell (2005) recommended exercising 
caution while interpreting results where this issue may be present. 
External validity refers to the ability of the general population to extrapolate a 
study’s findings. The results of my study may not be generalizable to a population of 
employees in organizations outside of the pharmaceutical scope. Such organizations were 
not my focus, and are thus irrelevant to the findings. In addition, the allowance of 
participants to take the survey assessments online presented the concern of situational 
validity. Participants may have been in an uncomfortable area, or under conditions that 
may have altered their responses. This was compounded by the cross-sectional nature of 
the study, wherein a single opinion was gathered at one point in time. Potential issues 
arise if a participant was in an extreme mood, or was suffering from any maladies, which 
may detriment the accuracy of the responses (Mitchell & Jolley, 2001). However, I 
encouraged participants to take their time, and provide broad, honest responses. 
Ethical Procedures 
A researcher who conducts studies involving human subjects has a responsibility 




research study, I adhered to the ethical and moral guidelines prescribed by federal 
regulations and Walden University’s Institution Review Board (IRB). I interacted with 
human subjects during this study. My data collection approach entailed the use of a single 
compiled survey instrument, administered at only one point in time. The compiled survey 
included two sets of questions. These included the pharmaceutical industry questions and 
the measures of behavioral support for change questions. Additionally, I used notification 
memoranda to invite participation. The following section entails the approach to 
informed consent and a brief discussion on data storage, retention, and destruction to 
protect confidentiality.  
The survey instrument for this study was designed to minimize the need to collect 
identifiable data. In accord with IRB and federal guidelines, I safeguarded all data and 
information to protect confidentiality. The safeguard measure for data storage was a 
locked file in my residence where I will retain the data securely for a period of 5 years 
after the research was completed. Upon expiration of the 5-year retention period, I will 
permanently destroy all research-related data and information pertaining to this study. 
Summary 
In this chapter, I outlined the quantitative design, as well as rationale for the use 
of this research method. I also described the stratified sampling method used to gather 
participants from the population of pharmaceutical industry professionals who had 
experienced at least one large-scale organizational change. Additionally, I 
operationalized the variables of interest, and included the instrumentation and procedures 




in addressing the hypotheses, and included a rationale for the analyses and the 
presentation of results. Finally, I addressed limitations and ethical concerns, with special 
consideration of methods that may remedy these potential difficulties or harms. I adhered 
strictly to these procedures in gathering and analyzing data to cleanly and efficiently 




Chapter 4: Results  
The purpose of this quantitative, correlational study was to narrow the knowledge 
gap on large-scale organizational change in the pharmaceutical industry. Researchers 
have sought to understand employee engagement and response during large-scale change 
initiatives in nonpharmaceutical industries (Goksoy et al., 2012; Herscovitch & Meyer, 
2002; Lau & Woodman, 1995; Oreg & Sverdlik, 2011). However, employee responses to 
change in the pharmaceutical industry remain understudied and underrepresented. In the 
study, I tested four factors that I hypothesized affect the change’s implementation: ICR, 
ICD, PCS, and CHC; these factors functioned as independent/predictor variables in this 
study. The dependent variables were RC, which included the full spectrum of reactions 
ranging from active resistance to championing change and operationalized measures of 
SC (CM, CP, and CH). One additional dependent variable, SC, represented a composite 
index of support of change, and was calculated as the mean of the three subscales (CM, 
CP, and CH). 
This chapter describes the pre-analysis data screening that I performed prior to 
conducting the multiple regression analyses to explore the two research questions. In it, I 
review demographic information and descriptive statistics prior to presenting the detailed 
analyses ordered by research question. For each analysis, I assess the assumptions of 
normality, homoscedasticity, and absence of multicollinearity before accepting or 
rejecting the appropriate hypotheses based on the results. I also include a summary of the 




Field Test and Pre-Analysis Data Screening 
I used the first 11 completed responses as a field test to assess the quality of the 
responses and to determine whether the right participants were responding to the survey. 
A few respondents listed job roles, such as cashier, that did not appear consistent with 
those in the pharmaceutical industry. Three respondents selected other and wrote not 
applicable as their pharmaceutical industry job category. Based on these initial responses, 
I decided to add a screening question that specifically asked participants if they work in 
the pharmaceutical industry. Those who answered no were disqualified, and those who 
answered yes were allowed to complete the survey. These first 11 completed surveys 
were therefore not included in the final analysis, as it was hard to determine with 
certainty that the respondents worked in the pharmaceutical industry. 
Data Collection and Sample Characteristics 
I collected data over a 2-week time frame in July 2015. A total of 914 people 
attempted to access the online survey. Of these, 816 either did not fit the inclusion criteria 
or did not consent to the survey and were removed from the dataset. I then assessed the 
data for nonrandom missing cases and did not find any. I further checked for univariate 
outliers by examination of standardized values, which indicate the distance a participant’s 
score falls from the mean, and is measured in standard deviations. I considered any cases 
3.29 standard deviations away from the mean as outliers to be removed (Tabachnick & 
Fidell, 2012). As I did not find any outliers in the data, the final dataset contained a total 




Of the 98 participants in the final data set, 45% were male (n = 44) and 55% were 
female (n = 54). Many were between 30 and 44 years of age (42, 43%) and reported 
household earnings between $50,000 and $74,999 per year (15, 15%). The largest 
proportion of participants came from the mid-Atlantic region of the United States (20, 
20%). Of the pharmaceutical industry job category options, the largest group of 
participants was researchers (18, 18%). Many of the participants’ highest level of 
education was a Bachelor’s degree (38, 39%). A large portion of the participants’ 
companies underwent a merger or acquisition as a large-scale organizational change (35, 
36%). This mix of participants approximately represents the employee mix at a typical 
pharmaceutical company. The frequencies and percentages of demographic information 






Frequencies and Percentages of Demographics 
Demographic n % 
 
What is your gender?   
 Male 44 45 
 Female 54 55 
What is your age range? 
 18 – 29 years 12 12 
 30 – 44 years 42 43 
 45 – 59 years  32 33 
 60 + years 12 12 
How much total combined money did all members of your household earn last year? 
 $10,000 to $24,999 2 2 
 $25,000 to $49,999 14 14 
 $50,000 to $74,999 15 15 
 $75,000 to $99,999 13 13 
 $100,000 to $124,999 8 8 
 $125,000 to $149,999 11 11 
 $150,000 to $174,999 4 4 
 $175,000 to $199,999 1 1 
 $200,000 and up 14 14 
 Prefer not to answer 16 16 
United States Region   
 New England  16 16 
 Middle Atlantic 20 20 
 East North Central 15 15 
 West North Central 7 7 
 South Atlantic 12 12 
 East South Central 4 4 
 West South Central 3 3 
 Mountain  9 9 
 Pacific 10 10 
 Prefer not to answer 2 2 
Select the pharmaceutical industry category that best describes your job role? 
 Executive (e.g., Vice President) 7 7 
 Management (e.g., Manager, Director) 17 17 
 Professional (e.g. Project management, Marketing) 10 10 
 Support (e.g., Information technology) 12 12 
 Research (e.g., Scientist) 18 18 




 Other 33 34 
What is the highest level of education you have completed?    
 High school or equivalent 24 25 
 Bachelor’s Degree  38 39 
 Master’s Degree 17 17 
 Doctorate or other advanced degree (e.g., PhD, MD, PharmD) 19 19 
What best describes the large-scale organizational change you 
experienced? 
  
 Merger or acquisition 35 36 
 Major process redesign 17 17 
 Restructuring 22 22 
 Downsizing 12 12 
 Upsizing 7 7 
 Other large-scale change  5 5 
 
Note. Due to rounding errors, not all percentages may sum to 100. 
Participants in the sample demonstrated a wide range of years spent in the 
pharmaceutical industry, where the minimum was one year and the maximum amount of 
time spent was 56 years. Visual examination of the variables germane to the study 
revealed that the lowest scores tended to be found in the ICD variable, where none 
responded with higher than a value of three out of seven. This is reflected in the mean 
value, which was also found to be much lower than any other independent variable. The 






Descriptive Statistics of Continuous Variables 
Composite Scores Min. Max. M SD 
 
Years in the Pharmaceutical Industry 1 56 14.39 12.37 
ICR 1 7 3.49 1.39 
CHC 1 7 3.44 1.81 
ICD 1 3 1.45 0.66 
PCS 1 7 3.96 1.65 
RC 0 100 58.29 20.77 
SC 61 80 70.94 3.64 
 
Reliability 
I conducted Cronbach's alpha tests of reliability and internal consistency on 
scales, with one test per scale. The Cronbach's alpha provides mean correlation between 
each pair of items and the number of items in a scale (Brace, Kemp, & Snelgar, 2006). I 
interpreted the alpha values using George and Mallery’s (2010) guidelines where α > .9 is 
excellent, >.8 is good, >.7 is acceptable, >.6 is questionable, >.5 is poor, and < .5 is 
unacceptable. Results for SC indicated excellent reliability (α = .93). Reliability statistics 






Cronbach’s Alpha Reliability Statistics for the Composite Score 
Scale # of Items α 
 
SC 17 .93 
 
Detailed Analysis 
Research Question 1: Reaction to Change (RC) 
1. What is the relationship between RC and the predictor variables ICR, ICD, PCS, 
and CHC? 
H01: No relationship exists between RC and the predictor variables ICR, 
ICD, PCS, and CHC. 
1 = 2 =  = k = 0. 
Ha1: A relationship exists between RC and the predictor variables ICR, 
ICD, PCS, and CHC.  
At least one j ≠ 0. 
To assess the first research question, I used a multiple linear regression to assess 
if the four independent variables (ICR, ICD, PCS, and CHC) predict RC. Prior to 
conducting the analysis, I assessed the assumptions of normality, homoscedasticity, and 
absence of multicollinearity. To check that the data fit a normal distribution, I checked 
the normal P-P plot to ensure that the data followed the normal line. As there were no 
large deviations from the normal line, the assumption was met (see Figure 2). To assess 




scatterplot of standardized residuals as a function of standardized predicted values. As the 
data points are rectangularly and randomly distributed around zero, the assumption was 
met (see Figure 3). I used VIFs to assess the assumption of absence of multicollinearity. 
Values for VIFs less than 10 indicate that there is not extreme multicollinearity (Stevens, 
2009). As the largest VIF in the model was 2.14, the assumption was met.  
 
Figure 2. Normal P-P plot to check whether data used to assess the relationship between 





Figure 3. Scatterplot of standardized residuals as a function of standardized predicted 
values for RC.  
 
As the assumptions were met, I proceeded with the regression analysis to 
determine whether ICR, ICD, PCS, and CHC significantly predict RC. The results of the 
analysis indicated that the model is statistically significant, F(4,93) = 5.50, p = .001, R2 = 
0.19 (see Table 4). The results of the multiple linear regression indicated that the null 
hypothesis was rejected in favor of the alternative, which states that a significant 






ANOVA Results for Regression One 
Source SS df MS F p 
      
Regression 8005.765 4 2001.441 5.499 .001 
Residual 33851.697 93 363.997   
Total 41857.462 97    
The R2 indicates that the model predicts 19% of the variability in the dependent 
variable. Although the model is significant, there were no significant individual 
predictors, as depicted by the t-statistics and p-values in Table 5. This is potentially due 
to issues of multicollinearity or shared significance among predictors, where the model 
would be unable to determine specifically where significance lies (Stevens, 2009). ICR 
approached significance, but ultimately was found to be insignificant at an alpha of .05 (B 
= 3.37, t = 1.92, p = .057). Because the regression equation was significant, the following 
equation may be used to predict RC:  
𝑅𝐶 = 3.37(𝐼𝐶𝑅) + 1.11(𝐶𝐻𝐶) − 0.49(𝐼𝐶𝐷) + 2.57(𝑃𝐶𝑆) + 33.26 
The results are presented in Table 5.  
Table 5 
Results for Multiple Linear Regression to Predict RC  
Source B SE β T(98) Critical t p 
       
Constant 33.26 6.29  5.29 1.98 .001 
ICR 3.37 1.75 0.23 1.92 1.98 .057 
CHC 1.11 1.53 0.10 0.73 1.98 .468 
ICD -0.49 3.23 -0.02 -0.15 1.98 .880 
PCS 2.57 1.72 0.20 1.49 1.98 .139 




Research Question 2: Support of Change (SC) 
2. What is the relationship between SC and the predictor variables ICR, ICD, PCS, 
and CHC? 
H02: No relationship exists between SC and the predictor variables ICR, 
ICD, PCS, and CHC. 
 1 = 2 =  = k = 0 
Ha2: A relationship exists between SC and the predictor variables ICR, 
ICD, PCS, and CHC. 
  At least one j ≠ 0 
I utilized four multiple linear regressions to assess Research Question 2. The first 
was to determine whether the four independent variables (ICR, ICD, PCS, and CHC) 
predict SC. I then examined the three individual regression equations where the 
dependent variables were the SC subscales of CM, CP, and CH. I checked assumptions of 
normality, homoscedasticity, and absence of multicollinearity before conducting the 
analysis. Normality assumes that the data follows a normal, bell-shaped distribution. I 
used a normal P-P plot to check the assumption. Since there were no large deviations 
from the normal line, the assumption was met (See Figure 4). To assess the assumption of 
homoscedasticity, or equal variance of error terms, I created a scatterplot of the 
standardized residuals as a function of the standardized predicted values. Since the points 
are in a rectangular, regular distribution, the assumption was met (See Figure 5). Absence 




assumption with VIFs such that a value of 10 indicates that there is multicollinearity in 
the predictors (Stevens, 2009). As the greatest value is 2.14, the assumption was met.  
 
 
Figure 4. Normal P-P plot to check whether data used to assess the relationship between 







Figure 5. Scatterplot of standardized residuals as a function of standardized predicted 
values for SC.  
As the assumptions were met, I ran the first multiple linear regression analysis for 
Research Question 2. The results of the regression indicated insignificance, F(4,93) = 
1.18, p = .326, R2 = 0.05 (See Table 6). For this research question, the null hypothesis 







ANOVA Results for Regression Two 
Source SS df MS F p 
      
Regression 61.991 4 15.498 1.178 .326 
Residual 1223.464 93 13.156   
Total 1285.455 97    
Based on the t-statistics and p-values in Table 7, I cannot conclude that the four 
predictors made a significant model to predict SC. The results of the regression are 
presented in Table 7.  
Table 7 
Results for Multiple Linear Regression to predict SC  
Source B SE β T(98) Critical t P 
       
Constant 68.55 1.2  57.34 1.98 .001 
ICR 0.25 0.33 0.10 0.76 1.98 .449 
CHC -0.16 0.29 -0.08 -0.56 1.98 .579 
ICD  0.56 0.61 0.10 0.91 1.98 .366 
PCS 0.32 0.33 0.14 0.97 1.98 .333 
Note. F(4,93) = 1.18, p = .326, R2 = 0.05 
 
Next, I conducted a third regression analysis to determine the collective 
relationship between the four independent variables (ICR, CHC, ICD, and PCS) and CM. 
I checked assumptions of normality, homoscedasticity, and absence of multicollinearity 
before conducting the analysis. Normality assumes that the data follows a normal, bell-
shaped distribution. I used a normal P-P plot to check the assumption. Since there were 
no large deviations from the normal line, the assumption was met (See Figure 6). To 




scatterplot of the standardized residuals as a function of the standardized predicted 
values. Since the points are in a rectangular, regular distribution, the assumption was met 
(See Figure 7). Absence of multicollinearity assumes that no two predictors are highly 
correlated. I checked this assumption with VIFs such that a value of 10 indicates that 
there is multicollinearity in the predictors (Stevens, 2009). As the greatest value is 2.14, 
the assumption was met.  
 
Figure 6. Normal P-P plot to check whether data used to assess the relationship between 






Figure 7. Scatterplot of standardized residuals as a function of standardized predicted 
values for CM. 
As the assumptions were met, I ran the multiple linear regression analysis. The 
results of the regression indicated insignificance, F(4,93) = 1.44, p = .227, R2 = 0.06 (see 
Table 8). For this research question, the null hypothesis that no relationship exists 






ANOVA Results for Regression Three 
Source SS df MS F P 
      
Regression 194.97 4 48.743 1.44 .227 
Residual 3146.871 93 33.837   
Total 3341.841 97    
Based on the t-statistics and p-values in Table 9, I cannot conclude that the four 
predictors made a significant model to predict CM. The results of the regression are 
presented in Table 9.  
Table 9 
Results for Multiple Linear Regression to Predict CM  
Source B SE β t(98) Critical t P 
       
Constant 49.36 1.92  25.75 1.98 .001 
ICR 0.83 0.53 0.20 1.55 1.98 .124 
CHC -0.74 0.47 -0.23 -1.60 1.98 .114 
ICD -0.68 0.98 -0.08 -0.69 1.98 .490 
PCS -0.13 0.52 -0.04 -0.25 1.98 .803 
Note. F(4,93) = 1.44, p = .227, R2 = 0.06 
 
Next, I conducted a fourth regression analysis to determine the collective 
relationship between the four independent variables (ICR, CHC, ICD, and PCS) and CP. 
I checked assumptions of normality, homoscedasticity, and absence of multicollinearity 
before conducting the analysis. Normality assumes that the data follows a normal, bell-
shaped distribution. I used a normal P-P plot to check the assumption. Since there were 
no large deviations from the normal line, the assumption was met (See Figure 8). To 




scatterplot of the standardized residuals as a function of the standardized predicted 
values. Since the points are in a rectangular, regular distribution, the assumption was met 
(See Figure 9). Absence of multicollinearity assumes that no two predictors are highly 
correlated. I checked this assumption with VIFs such that a value of 10 indicates that 
there is multicollinearity in the predictors (Stevens, 2009). As the greatest value is 2.14, 
the assumption was met.  
 
Figure 8. Normal P-P plot to check whether data used to assess the relationship between 






Figure 9. Scatterplot of standardized residuals as a function of standardized predicted 
values for CP. 
As the assumptions were met, I ran the multiple linear regression analysis. The 
results of the regression indicated insignificance, F(4,93) = 1.25, p = .296, R2 = 0.05 (see 
Table 10). For this research question, the null hypothesis that no relationship exists 
between the four predictor variables and CP was not rejected 
Table 10 
ANOVA Results for Regression Four 
Source SS df MS F P 
      
Regression 92.572 4 23.143 1.247 .296 
Residual 1725.633 93 18.555   




Based on the t-statistics and p-values in Table 11, I cannot conclude that the four 
predictors made a significant model to predict CP. The results of the regression are 
presented in Table 11.  
Table 11 
Results for Multiple Linear Regression to Predict CP  
Source B SE β t(98) Critical t P 
       
Constant 69.76 1.42  49.14 1.98 .001 
ICR -0.22 0.40 -0.07 -0.56 1.98 .575 
CHC -0.11 0.34 -0.05 -0.31 1.98 .754 
ICD 1.34 0.73 0.20 1.84 1.98 .069 
PCS 0.38 0.39 0.15 0.99 1.98 .325 
Note. F(4,93) = 1.25, p = .296, R2 = 0.05 
I conducted the final regression analysis to determine the collective relationship 
between the four independent variables (ICR, CHC, ICD, and PCS) and CH. I checked 
assumptions of normality, homoscedasticity, and absence of multicollinearity before 
conducting the analysis. Normality assumes that the data follows a normal, bell-shaped 
distribution. I used a normal P-P plot to check the assumption. Since there were no large 
deviations from the normal line, the assumption was met (See Figure 10). To assess the 
assumption of homoscedasticity, or equal variance of error terms, I created a scatterplot 
of the standardized residuals as a function of the standardized predicted values. Since the 
points are in a rectangular, regular distribution, the assumption was met (See Figure 11). 
Absence of multicollinearity assumes that no two predictors are highly correlated. I 




multicollinearity in the predictors (Stevens, 2009). As the greatest value is 2.14, the 
assumption was met.  
 
Figure 10. Normal P-P plot to check whether data used to assess the relationship between 






Figure 11. Scatterplot of standardized residuals as a function of standardized predicted 
values for CH. 
As the assumptions were met, I proceeded with the regression analysis to 
determine whether ICR, CHC, ICD, and PCS significantly predict CH. The results of the 
analysis indicated that the model is statistically significant, F(4,93) = 5.24, p = .001, R2 = 
0.18 (see Table 12). The results of the multiple linear regression indicated that the null 
hypothesis was rejected in favor of the alternative, which states that a significant 
relationship exists between the four predictor variables and CH. 
Table 12 
ANOVA Results for Regression Five 
Source SS df MS F P 
      
Regression 429.176 4 107.294 5.236 .001 
Residual 1905.832 93 20.493   




The R2 indicates that the model predicts 18% of the variability in the dependent 
variable. Although the model is significant, there were no significant individual 
predictors, as depicted by the t-statistics and p-values in Table 13. This is potentially due 
to issues of multicollinearity, or shared significance among predictors, where the model 
would be unable to determine specifically where significance lies (Stevens, 2009). 
Perceived change success was the closest to being significantly predictive of CH, but 
ultimately was found to be insignificant at an alpha of .05 (B = 0.70, t = 1.72, p = .089). 
Because the regression equation was significant, the following equation may be used to 
predict CH:  
𝐶𝐻 = 0.15(𝐼𝐶𝑅) + 0.37(𝐶𝐻𝐶) + 1.01(𝐼𝐶𝐷) + 0.70(𝑃𝐶𝑆) + 86.52 
The results are presented in Table 13.  
Table 13 
Results for Multiple Linear Regression to Predict CH  
Source B SE β t(98) Critical t P 
       
Constant 86.52 1.49  57.99 1.98 .001 
ICR 0.15 0.42 0.04 0.37 1.98 .716 
CHC 0.37 0.36 0.14 1.01 1.98 .313 
ICD 1.01 0.77 0.14 1.32 1.98 .189 
PCS 0.70 0.41 0.24 1.72 1.98 .089 
Note. F(4,93) = 5.24, p = .001, R2 = 0.18 
 
Summary of Results 
For Research Question 1, the results suggest that an aggregate model of ICR, 
CHC, ICD, and PCS predicts RC (F(4,93) = 5.50, p = .001, R2 = 0.19). However, the 




For Research Question 2, the results suggest that there is insufficient evidence to 
conclude that ICR, CHC, ICD, and PCS predict SC (F(4,93) = 1.18, p = .326, R2 = 0.05). 
However, ICR, CHC, ICD, and PCS, in the aggregate, were found to predict the CH 
subscale of SC (F(4,93) = 5.24, p = .001, R2 = 0.18). As in the regression used to predict 
RC, the model could not identify an individual independent variable with significant 
predictive ability. 
Summary of Chapter 
Chapter Four presented a brief summary of the purpose and problem statement to 
contextualize the results prior to discussing the field test and initial data-screening that 
occurred before presenting the analyses. I presented sample characteristics and 
descriptive statistics. I then described and presented detailed analyses in order of the 
relevant research questions and hypotheses. Finally, I examined the hypotheses so that 
they could be either accepted or rejected and concluded with a summary of the results. I 
will discuss the implications of these results in the next chapter in the context of the 
existing literature and practice. 
In summary, the four independent variables (ICR, CHC, ICD, and PCS) in the 
aggregate significantly predicted RC, and though they did not significantly predict SC 
overall, they did predict the CH subscale of SC. None of the independent variables 
individually predicted RC or SC. Of the four independent variables, ICR was the only one 
that trended towards predicting RC, but the association was not significant. Likewise, 
PCS was the closest variable to being a significant predictor of CH, though this 




Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this quantitative, correlational study was to narrow the knowledge 
gap on large-scale organizational change in the pharmaceutical industry. I did so by 
measuring whether any of several factors predict employee response to large-scale 
change initiatives, such as M&As, in the pharmaceutical industry. The independent or 
predictor variables were the four factors I hypothesized affect the change’s 
implementation: participants’ initial reactions, participants’ involvement in the change 
design, participants’ perceptions regarding the successfulness of the change, and the 
frequency and quality of communication about the change. The two dependent variables 
were reaction to change and operationalized measures of support of change. Reaction to 
change includes the full spectrum of reactions ranging from a negative reaction of active 
resistance to a positive reaction of championing change; operationalized measures of 
support of change is an index computed by combining the subscales of compliance, 
cooperation, and championing.  
The problem addressed in this study was a limited understanding of the factors 
that predict employee response to large-scale change in the pharmaceutical industry. 
Researchers have studied employee response to change in many industries, including law 
enforcement (Ford et al., 2003), the hospitality industry (Hartline & Ferrell, 1996), and 
the electronics industry (Goksoy et al., 2012). However, there was no information in the 
literature on the study of employee response to large-scale organizational change in the 




engages in M&As, a common type of large-scale organizational change, 50-80% of 
which usually fails, according to Budhwar et al. (2009), for reasons related to 
communication and employee engagement. Additionally, risk of failure is high in the 
pharmaceutical industry, as only 1 in 10,000 discovered compounds make it from the 
laboratory to market, according to Cook et al. (2009) and costs $1.8 billion in doing so, 
based on Golec et al.’s 2009 estimate. Failed mergers have immediate negative effects in 
the communities in which these pharmaceutical companies operate, as the failed entities 
may go out of business, resulting in major job losses. In addition to the financial and 
business challenges, a failed merger in the pharmaceutical industry has a significant 
potential to negatively affect the participating companies’ development of medicines and 
other medical innovations to fulfill global health needs.  
This chapter begins with a summary of the results of the study. I then interpret the 
results and discuss how they extend knowledge in the area of change management within 
the pharmaceutical industry. After reviewing key limitations, such as those related to the 
quantitative methodology and generalizability outside the pharmaceutical industry, I 
present recommendations for future research, review implications for organizational 
change and positive social impact, and conclude after discussing recommendations for 
professional practice. 
Summary of Key Results 
This study was designed to answer two research questions: 





2. What is the relationship between SC and the predictor variables ICR, ICD, PCS, 
and CHC? 
For Research Question 1, the results suggest that in the aggregate, the four 
independent variables predict reaction to change. However, none of the predictors 
individually predicted reaction to change.  
For Research Question 2, the research failed to find sufficient evidence to 
conclude that the factors, in the aggregate, predict support of change. However, the 
factors in the aggregate, were found to predict the championing sub-scale. As in the 
regression used to predict reaction to change, the model could not identify an individual 
independent variable with significant predictive ability. 
Interpretation of Results 
How Results Confirm and Disconfirm Knowledge in the Discipline 
Reaction to change. I selected the factors evaluated in my study because 
previous researchers found that one or more of these factors predicted employee response 
to change and lead to change success in other industries. These industries included law 
enforcement (Ford et al., 2003), the hospitality industry (Hartline & Ferrell, 1996), the 
electronics industry (Goksoy et al., 2012), and the publishing industry Franckeiss (2012). 
In a 2012 study of a global print-based publishing company that was transitioning to 
digital formats, Franckeiss found that various hands-on change inclusion techniques and 
frequent change communication through webinars before, during, and after change 
implementation increased change success. Goksoy et al. (2012) found that 




organizational change. My results, however, did not align with the findings of previous 
studies, as none of the factors (participants’ initial reactions, involvement in the change 
design, perceptions regarding the successfulness of the change, or communication about 
the change) individually predicted employees’ reaction to change.  
However, my results did support previous research that showed change is 
multidimensional and best examined through multidimensional approaches (Herscovitch 
& Meyer, 2002). It is likely that there are different factors related to employee reactions 
to change in the pharmaceutical industry than those of other industries. Additional factors 
related to employee reactions to change from recent research have included behavioral 
and attitudinal components (Jaros, 2012), emotional factors (Mishra & Bhatnagar, 2010), 
and factors related to employees’ ambivalence toward change (Oreg & Sverdlik, 2011). 
In addition, recent research in other industries found that change leadership 
(Charbonnier-Voirin, El Akremi, & Vandenberghe, 2010; Ricke-Kiely & Robey-
Williams, 2011; Wang & Rode, 2010) and employees’ prior change experiences (Bordia 
et al., 2011) both predict employees’ reactions to change. These prior findings all suggest 
that a combination of factors influence employee reaction to change.  
These two factors (change leadership and employees’ prior change experiences) 
might be related to employees’ reaction to change in the pharmaceutical industry as well 
and could be the subject of future research. In addition, Oreg and Sverdlik (2011) found 
that employees’ reactions to change could be ambivalent, suggesting the necessity of 
more nuanced approaches to employees’ reactions to change that can account for how 




about the change agent) aspects of the same change. Although change may be best 
approached as a multidimensional construct, as it is in other industries, it may be 
necessary for researchers to discover what specific individual factors relate to employee 
reaction to change in the pharmaceutical industry.  
Support of change. Based on a review of the literature, I hypothesized that the 
opinions employees form or behaviors they exhibit upon first learning about a change 
predict or influence how much they support the change. I also hypothesized that the 
quality and frequency of the initial and subsequent change communication, the level of 
employee involvement in the change development, and perceptions of the change’s 
success influence the degree to which employees support change in the pharmaceutical 
industry. However, my results in the pharmaceutical industry did not confirm previous 
findings from other industries that employee involvement in change or communication 
regarding change, taken individually or in the aggregate, predict their support of change. 
Jaros (2010) and Whelan-Berry and Somerville (2010) found that employee involvement 
in change predicted employee support of change. Jaros (2010) found that getting 
employees to commit to new procedures, policies, and goals involving change increased 
the likelihood of change success. This means that other factors specific to the 
pharmaceutical industry could influence employee support of change and are worth 
evaluating in a future study.  
The commitment to the new operating norm Jaros (2010) described may be hard 
to achieve without a comprehensive, multidimensional approach to change management. 




component of large-scale change that change leaders and human resource personnel are 
responsible for, which is often overlooked during change implementation. In the same 
study, Whelan-Berry and Sommerville mentioned communication and employee 
participation among the contributors to successful change. In addition, Goksoy et al. 
(2012) and Whelan-Berry and Somerville found that clear communication regarding 
organizational change was important for employee adoption and support of change. 
 Much of the relevant literature appears to support my results related to reaction to 
change, that a number of factors in the aggregate foster a positive reaction to change. 
However, when comparing existing literature to my results related to support of change, 
the result is different, as the four independent variables in the aggregate did not predict 
support of change. When the subscales of support of change were isolated and considered 
separately, however, the independent variables in the aggregate predicted the 
championing subscale. Individually, none of the independent variables predicted support 
of change or any of its subscales. 
 Reflecting on the responses on the change continuum ranging from active 
resistance to championing change, only 5.1% of the 98 participants fell in the 
championing change category (See figure 12). This 5.1% is an interesting result because 
the four independent variables predicted championing, indicating that when employees 
display the most enthusiastic, supportive change behaviors, the change is likely to be 
successful, provided other aspects of the change are proceeding well. My results on 
employees’ championing change suggest connections between employees’ support of 




next section. Employees are supportive and enthusiastic when they feel they are 
important to an organization’s overall success and when leaders treat them as 
stakeholders (Duckworth, 2014). Viewing employees as stakeholders with an interest in 
an organization’s overall success may help change leaders and managers establish 
bottoms-up approaches to include employees in change processes and to facilitate 
employees’ championing of change (Duckworth, 2014) to ensure change success. 
 
Figure 12. The distribution of responses to reaction to change. 
Interpretation of Results in Relation to Theoretical Framework 
I framed this study with a synthesis of transformational leadership theory, 
stakeholder theory, and change management theory. I selected these theories because 
they all relate to employee engagement during organizational change. Burns’s (1978) 
transformational leadership theory involves the use of motivation and inspiration to 
obtain desired actions and outcomes from employees. It is also considered a reciprocal 














success, according to Burns. Freeman’s (1984) stakeholder theory is about justice, 
acknowledgment, and fair treatment of those with a vested interest or stake in an 
organization. Finally, and since change usually involves some disruption, Lewin’s (1947) 
3-stage change management model, which is to unfreeze the current situation, make the 
change, and then stabilize or refreeze the situation, seemed an appropriate theoretical 
framework to understand change processes in relation to the pharmaceutical industry. 
Lewin’s 3-stage change management model offered a theoretical lens through which to 
examine initial change reaction, involvement in change design, perceived change success, 
and change communication in relation to large-scale change of established practices in 
the pharmaceutical industry.  
Based on the results of my study, it may be possible to construct a more effective 
change management process with an optimum mix of leadership and employee 
engagement. Charbonnier-Voirin et al. (2010) noted that transformational leadership is 
the type required for effective change management because transformational leaders use 
motivation and inspiration to help employees adapt to organizational change. 
Charbonnier-Voirin et al. contended that creating a work environment conducive to 
innovation fosters better change adoption at individual and team levels. Actual 
characteristics or predispositions that would create that environment and signal how 
employees respond to change, however, were not addressed. Similarly, Wang and Rode 
(2010) discussed a comprehensive approach to change that emphasized the value of 
context in facilitating change. According to Wang and Rode, employee engagement 




however, can be optimized in an innovative, transformational leadership environment, 
where employees identify with leaders. In my study, I isolated a combination of four 
factors (initial change reaction, involvement in change design, perceived change success, 
and change communication) that can assist, in the aggregate, in creating such an 
environment. In addition, transformational leadership techniques, such as motivation, 
inspiration, and recognizing that employees are important stakeholders, may help change 
leaders engage better with employees during organizational change to help ensure change 
success. 
Successful organizational change requires a balanced approach that acknowledges 
various stakeholder needs. According to Duckworth (2014) and Parmar et al. (2010), 
decisions and actions regarding change intimately and directly affect employees. For this 
reason, employees are important stakeholders to engage in organizational change. 
Applying stakeholder theory, employees may be considered crucial stakeholders in an 
organization, and research (Jaros, 2010; Whelan-Berry & Somerville, 2010) shows that 
employees’ participation in change endeavors is a key factor to successful organizational 
change implementation. A balanced, stakeholder-oriented approach to organizational 
change should address the views, concerns, needs, and efforts of various stakeholders, 
especially those of employees, when considering and managing change. An integrated 
approach that considers employees as important stakeholders to engage in organizational 
change necessary for change success, may also include a balanced approach that 
considers all of the variables of initial change reaction, involvement in change design, 




In addition, my results related to the championship subscale suggest a connection 
between seeing employees as stakeholders and employees championing change. 
Employees are supportive and enthusiastic when they are involved, feel instrumental to 
an organization’s overall success, and when leaders treat them as stakeholders 
(Duckworth, 2014). My results on the championing change sub-scale suggests that 
transformational leadership during change might include ensuring that employees are 
made to feel like stakeholders with an interest in the organization. In addition, 
stakeholder theory may offer a way to better understand that successful change should 
include a balanced approach that considers a variety of strategies when it comes to 
employee concerns, and may have a specific connection to employees championing 
change by involving them and making them feel crucial to an organization’s success. 
Although Lewin’s (1947) 3-stage change management model has become 
foundational to the study of organizational change, Marks and Mirvis (2011) cautioned 
that there is no one-size-fits-all approach to organizational change. The results of my 
study suggest that factors connected to the unfreezing of established approaches (i.e., 
reaction to change and support of change; Whelan-Berry & Sommerville, 2010) could not 
be predicted by initial change reaction, involvement in change design, perceived change 
success, and change communication, individually. Consequently, the results do not 
support targeting any of these components individually to help successfully unfreeze 
established practices in facilitating successful change. However, initial change reaction, 
involvement in change design, perceived change success, and change communication 




established practices in relation to reaction to change and the championing subscale of 
support of change.  
The findings from this study partially support the use of Lewin’s change 
management model in relation to information regarding reaction to change and the 
championing subscale of support of change. The findings of this study do not support the 
use of the unfreezing stage of Lewin’s change management model to inform support of 
change. This is the case because the four independent variables (initial change reaction, 
involvement in change design, perceived change success, and change communication) 
did not predict support of change individually or in the aggregate, but it could be used for 
the championing subscale of support of change. 
How Findings Extend Knowledge in the Discipline 
Major change initiatives are usually initiated in response to internal and external 
pressures. Organizations merge and remove management layers in response to a 
challenging economic climate. Fletcher (2009) likened this need for change or adaptation 
to that of a burning platform. In discussing this burning platform metaphor, Fletcher 
noted that organizations make bold, radical moves to stay competitive. Other researchers 
have taken a different perspective. According to Judge, Bowler, and Douglas (2006), 
organizations do not need to wait until they are essentially forced to change, and should 
always be prepared for change. According to Judge et al., organizations should have a 
change strategy that includes a contingent of change agents who are ready to facilitate 
change initiatives. Lucey (2008) concurred with this perspective and suggested that 




these change agents is to ensure that employees at all levels of the organization are 
involved in the change. Change agents can do so through soliciting feedback in informal 
settings and delivering the feedback to management for action and communication back 
to employees. 
Change initiatives have not traditionally focused on people as the primary target. 
According to Pellissier (2011), regardless of the change rationale, change model, 
philosophy, and selected change management tools, the emphasis of change initiatives is 
usually directed at specific processes or products. When employee response to change 
has been studied, it has been in other industries. Researchers have not paid enough 
attention to how engaged employees are during the change process in the pharmaceutical 
industry.  
My study, however, adds important, empirical data to the change management 
literature on employee response to change in the pharmaceutical industry. We now know 
that a combination of actions representing the four independent variables (initial change 
reaction, involvement in change design, perceived change success, and change 
communication) influences reaction to change. We also know that in the pharmaceutical 
industry, these variables independently do not influence reaction to change. When 
focused on the supportive side of employee response to change, ranging from mere 
compliance to championing, the four independent variables (in the aggregate or 
individually) did not influence support of change. However, the four independent 
variables significantly predicted the championing subscale of support of change. In 




stakeholder theory, but to a lesser extent the use of Lewin’s change management model 
to inform and frame organizational change. This is useful information for pharmaceutical 
organizations contemplating large-scale change such as M&As. 
Limitations of the Study 
Limitations to Generalizability 
The focus of this study was on the pharmaceutical industry, specifically on how 
pharmaceutical industry employees perceived large-scale organizational change. The 
sample included a diverse set of pharmaceutical industry job roles, including research 
scientists; support roles, such as IT and project management; executives; middle 
management; and one change management expert. This mix of job roles approximately 
reflects the typical distribution of job roles at a pharmaceutical company. Consequently, 
the results may be generalizable within the pharmaceutical industry. Beyond the 
pharmaceutical industry, however, the results may not be applicable and need to be 
interpreted with caution. 
Limitations to Validity and Reliability 
One key assumption in the proposal was that participants would respond honestly 
to the survey questions. There is no evidence to believe that participants were dishonest 
or thoughtless in responding to the survey. The Cronbach’s alpha reliability analysis for 
the support of change variable had excellent reliability (α = .93). This degree of reliability 





Another potential area of concern was ensuring that each participant completed 
only one survey. The Survey tool tracked the IP address of the participants’ devices and 
assigned a unique participant code. There was also no evidence that any participant 
completed more than one survey. The above concern represented potential limitations 
that did not affect the validity and reliability of this study.   
Potential limitations to internal validity arise when assumption tests indicate a 
violation to a statistical assumption (Stevens, 2009). In my study, each of the assumptions 
of the analyses (i.e., normality, homoscedasticity, and absence of multicollinearity) was 
met, and the analyses may be assumed to be accurate and empirically valid. In addition, 
the final sample used in the analysis was found to be sufficiently large to carry out the 
regression analyses based on an a-priori sample size calculation, which contribute to 
trustworthy results.  
Recommendations for Future Research 
 The sample contained a diverse mix of pharmaceutical industry employees, 
including scientific research roles, various project management and supportive roles, as 
well as management and executive roles. There was also one change management expert 
and a large category of other roles. One suggestion for future research is to segment and 
categorize pharmaceutical industry employees and study whether different groups, based 
on position, level, or role, respond to change differently. For example, a pharmacist, 
treating physician or nurse interacting directly with patients may not respond to change 
the same way a pharmaceutical company employee would. This difference could be 




directly and are more focused on discovery, development, and commercialization of 
pharmaceutical products, giving them a different perspective. Although both categories of 
employees share the same goal of improving lives through their work, their contribution 
and vantage points are quite different. In addition, employees may have differing roles in 
organizational change based on their positions and levels that would affect how they 
respond to change. It would therefore be interesting to see if these differences could be 
examined in a scholarly study. 
My selection of a quantitative method to study employee response to change in 
the pharmaceutical industry means that I traded rich details, typically associated with 
qualitative research, for statistical certainty that associations did not occur by chance. The 
four independent variables, together, significantly predicted reaction to change as well as 
the championing subscale of support of change. Although there was no individual 
predictor, initial change reaction came close to predicting reaction to change and 
perceived change success came close to predicting the championing subscale of support 
of change. Both of these variables could influence change communication and are worth 
further study using either a qualitative or mixed method approach to get a deeper 
understanding of the potential role initial change reaction and perceived change success 
play in facilitating successful organizational change. 
Avenues for future research might also include study of the format or type of 
communication used to inform employees initially of change in relation to ICR. The form 
of communication used to convey the information might influence employees’ initial 




take the form of a live, in-person meeting, a web-based meeting with video, a 
teleconference, a memo sent through the mail or email. Since the type of the initial 
change communication can vary, the type of format used to convey organizational change 
might influence employees’ initial reaction to change. 
The results also suggest that more research is needed to identify other predictive 
factors in relation to employees and change that are specific to the pharmaceutical 
industry. These might include employees’ ambivalence toward change (Oreg & Sverdlik, 
2011) and prior change experiences (Bordia et al., 2011). Additionally, researchers might 
also test how stakeholder theory is related to employees championing change and their 
support and enthusiasm for change when they are involved and feel they are important to 
an organization’s overall success as stakeholders. 
Implications 
Organizational Change Implications 
Of the 98 participants in my study, only 3.1% described themselves as having 
actively resisted change, and only another 11.2% passively resisted change. Although it is 
possible that respondents to this type of survey were those more likely to support change, 
organizations should be encouraged by the low percentage of employees who resist 
change. This finding creates an opportunity for organizations to leverage the fact that the 
vast majority of employees support organizational change. What is interesting, however, 
is that of those who supported change, a majority (60.7%) simply comply, providing 
minimal support. Organizations can create a more targeted approach to change 




and help convert some employees passively resisting change and move the compliant 
employees up the reaction to change continuum, making them more supportive of 
change.  
The results imply that a combination of factors, such as initial change reaction, 
involvement in change design, perceived change success, and change communication, 
can facilitate a better reaction to change. Large-scale changes, such as M&As, are 
strategic events with several proprietary and confidential elements. This poses a 
communication challenge to senior management, who may not be authorized to share 
many aspects of the change freely. This reality makes it difficult to incorporate the 
findings of this study in the design and implementation of organizational change, as 
communication and employee involvement are vital to the way employees react to 
organizational change. Therefore, managers contemplating change need to consider and 
decide from the outset what information to share with employees, communication 
frequency, and how much to engage employees in the process. This practice may be 
different from the traditional approach of focusing on the financial and regulatory aspects 
of the deal first, then worrying about change implementation and employee reaction later.  
Positive Social Change Implications 
Pharmaceutical industry employees are very much interested in creating social 
change. The intent of their research and development efforts is frequently to discover and 
develop medicines that fulfill unmet medical needs and improve the quality of life of 
individuals in societies around the world. In many cases, the medicines and other 




positive impact of their work on social change. Given the magnitude of the opportunity 
for social change in this profession, it is important for socially responsible organizations 
to create an environment in which such employees can have their greatest impact. Such 
environment can lead to better performance and focus during organizational change, 
effectively enabling employees to fulfill their mission of improving lives through their 
work developing medical innovations.   
With this new knowledge of the key factors that predict employee reaction to 
change, the industry is positioned to implement sound change management practices 
during organizational change. To improve the probability of a more positive change 
reaction, all four independent variables must be considered before, during and after 
implementing large-scale change, as individually they do not influence reaction to 
change. Although the association was only directional and not significant, based on the 
multiple regression analysis, change leaders should pay particular attention to the mode 
and content of the initial change communication, as it could influence whether employees 
support or resist organizational change.  
Recommendations for Practice 
In announcing organizational change initiatives, especially those as large as an 
M&A, organizations must be careful in communicating the right type and amount of 
information. Although all affected parties can benefit from a general overview of the 
change, each stakeholder or category of stakeholders will need more information on 




should create a change communication plan that addresses this need. Table 14 is an 
example of the diversity in information needs related to a contemplated change. 
Table 14 




Managers Primary Intended business benefits and resources 
needed 
Employees who execute 
the process 
Primary Reason for change in process and detailed 
procedures 
Process management head 
or change management 
professional 
Primary Realization metrics and scope of change 
Other functional areas Secondary Awareness of process change 
External clients Secondary Awareness of process change components 
that affect interactions with them 
A well-coordinated process that considers a variety of change dimensions is 
needed for successful change implementation. Such a process might consist of an 
approach that does not single out any one factor, but employs a combination of four 
factors (initial change reaction, involvement in change design, perceived change success, 
and change communication) that can assist in creating an environment of successful 
organizational change in pharmaceutical organizations. A well-coordinated process might 
also ensure that key players are aware of the decisions and the role they need to play to 
support it. Watson (2005) described this process as policy deployment, the second of a 
four-step approach to organizational strategy. The other steps are policy setting, 




except that Watson begins with an identified solution and focuses on achieving the 
intended goals of that solution. 
In addition to communication and employee involvement, good process 
management is essential to successful change implementation. In a large-scale 
organizational change situation, such as an M&A, the organizations should consider 
using various process management tools to foster communication up, down, and across 
the organization. First, the organizations should establish a process realization office. 
This office would be responsible for coordinating all formal integration-related 
communication, including town hall meetings to present high-level integration strategies. 
This central office could serve as a trusted source of merger- or integration-related 
information, create consistency in messaging, and represent a communication brand for 
the change initiative. With such an organized process, employees would know where to 
go for reliable organizational change information. 
Second, it is useful to establish a network of change agents to solicit feedback 
from peers in informal settings. According to Barratt-Pugh et al. (2013), in a study of the 
merger of two state government departments in Western Australia, employees had a 
positive experience with change when change agents used informal, relational techniques. 
With the feedback from the informal interactions, change leaders can adjust aspects of the 
implementation plan to meet stakeholder needs more effectively. This network of change 
agents will address a critical need to acknowledge and respond to stakeholder concerns 




vehicle even after the major change decisions have been made can be a useful way to 
gain additional support for the change.  
As noted in the sample characteristics, one participant was a change management 
expert with six sigma expertise. A close examination of the responses from this 
participant revealed that the participant responded very positively to the questions related 
to the championing subscale of support of change. The participant was actively involved 
in the change process, perceived the quality and frequency of change-related 
communication highly favorably, and scored perceived change success very highly. The 
responses also indicate that the participant maintained an optimistic perspective of the 
change and influenced others to support the change. This participant essentially modeled 
the behaviors implied in my recommended actions to improve the probability of 
successful organizational change in the pharmaceutical industry. 
These recommendations, if executed well, may foster a positive or supportive 
reaction to change. They address aspects of the four independent variables, which my 
study demonstrated influences reaction to change and the championing subscale of 
support of change when considered in the aggregate. The communication plan ensures 
the frequency and quality of communication, which can in turn elicit a positive initial 
reaction if handled well. Leveraging a network of change agents to interact with 
employees at all levels of the organization is a good way to keep employees involved. 
Doing so gives employees a voice and a feeling that their opinions and concerns matter, 





The purpose of this quantitative, correlational study was to narrow the knowledge 
gap on large-scale organizational change in the pharmaceutical industry. This was an 
important study because the pharmaceutical industry frequently engages in M&As, a type 
of large-scale organizational change, 50-80% of which fail because of poor 
communication, lack of employee involvement, and clashing corporate cultures, 
according Budhwar et al. (2009). Researchers have studied employee response to 
organizational change in many industries, including law enforcement (Ford et al., 2003) 
the hospitality industry (Hartline & Ferrell, 1996), and the electronics industry (Goksoy 
et al., 2012). However, they have not focused on employee response to change in the 
pharmaceutical industry, even though Cook et al. (2009) and Golec et al., (2009) 
indicated that it is one of the most expensive and high-risk industries. It is also an 
industry with strong potential for positive social change impact due to the nature of the 
work discovering and developing medical innovations to save and improve lives, while 
fulfilling global health needs.   
The results indicate that deploying a change management strategy that considers a 
combination of four factors, which were the independent variables in my study, can foster 
a positive, supportive employee reaction to change in the pharmaceutical industry. These 
four factors were initial change reaction, involvement in change design, perceived change 
success, and change communication. These individual factors on their own may not result 
in a positive response to change, as individually, they were not significant in any of the 




organizational change, managers should create a targeted change management strategy 
that, at a minimum, includes a contingent of change agents to facilitate informal 
employee engagement, a stakeholder information needs analysis for timely and relevant 
dissemination of information, and a process realization office responsible for 
communication quality, frequency, and consistency. 
Although the results of my study confirm that change is best examined as a 
multidimensional construct, the factors of the construct might be particular to the 
organizational needs and change dynamics of the pharmaceutical industry. As such, the 
study offers researchers encouragement and direction to identify additional factors, 
specific to the pharmaceutical industry, which may predict employee response to change. 
It also creates an opportunity to develop a better understanding of the connection between 
employee support of change and the enthusiasm employees feel for change as 
stakeholders. Finally, the findings that only a small percent of employees resist change 
and majority of those who support change merely comply, is an opportunity for managers 
to create enthusiasm and build support for change, starting with the initial change 
communication. Doing so might convert some of the few that may otherwise resist 
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